InterventionName_lower,Freq
,923
placebo,657
hydroxychloroquine,110
standard of care,84
convalescent plasma,62
no intervention,61
remdesivir,51
questionnaire,48
tocilizumab,44
azithromycin,40
ivermectin,35
survey,34
placebo oral tablet,33
favipiravir,29
blood sample,28
standard care,24
covid-19 vaccine,21
dexamethasone,21
methylprednisolone,18
nitazoxanide,18
enoxaparin,18
usual care,17
placebos,16
vitamin d,16
colchicine,16
vitamin c,16
blood sampling,15
normal saline,15
data collection,15
bnt162b2,15
standard of care (soc),14
questionnaire administration,13
control,13
saline,13
hydroxychloroquine sulfate,13
prone position,13
questionnaires,12
online survey,12
lung ultrasound,12
anakinra,12
lopinavir/ritonavir,12
baricitinib,11
covid-19 convalescent plasma,11
nasopharyngeal swab,11
mrna-1273,11
ruxolitinib,10
camostat mesilate,10
standard treatment,10
azd1222,10
zinc,9
control group,9
losartan,9
observational,9
rivaroxaban,8
vitamin d3,8
bcg vaccine,8
quality-of-life assessment,8
blood test,8
gam-covid-vac,8
interferon beta-1a,7
interview,7
camostat,7
saliva collection,7
covid-19,7
biospecimen collection,7
prone positioning,7
sarilumab,7
telerehabilitation,7
placebo administration,7
covid-19 pandemic,7
ad26.cov2.s,7
observation,7
bamlanivimab,7
chloroquine,7
cholecalciferol,7
vir-7831,7
recombinant novel coronavirus vaccine (adenovirus type 5 vector),7
standard therapy,6
hydroxychloroquine (hcq),6
nafamostat mesilate,6
standard medical treatment,6
oseltamivir,6
heparin,6
soc,6
anti-sars-cov-2 convalescent plasma,6
uc-mscs,6
mesenchymal stromal cells,6
das181,6
melatonin,6
interferon beta-1b,6
best practice,6
online questionnaire,6
aspirin,6
blood draw,6
azd7442,6
niclosamide,5
pulmonary rehabilitation,5
clazakizumab,5
covid-19 vaccines,5
povidone-iodine,5
ly3819253,5
sars-cov-2 convalescent plasma,5
therapeutic plasma exchange,5
fluvoxamine,5
standard of care treatment,5
infliximab,5
survey administration,5
prednisone,5
telemedicine,5
ampion,5
serology,5
exercise,5
blood samples,5
ascorbic acid,5
coronavac,5
blood tests,5
rt-pcr,5
sargramostim,5
questionnaire assesment,5
0.9% saline,5
echocardiography,5
mavrilimumab,5
other,4
tofacitinib,4
placebo capsules,4
hydroxychloroquine + azithromycin,4
cellectra® 2000,4
famotidine,4
rls-0071,4
human biological samples,4
adsorbed covid-19 (inactivated) vaccine,4
had5-s-fusion+n-etsd vaccine,4
low dose radiotherapy,4
dwrx2003,4
opaganib,4
hcq,4
spirometry,4
saliva sample,4
chloroquine or hydroxychloroquine,4
covi-amg,4
scta01,4
regn10933+regn10987 combination therapy,4
covi-msc,4
placebo comparator,4
anti-sars-cov2 serology,4
n-acetylcysteine,4
lopinavir / ritonavir,4
observational study,4
proxalutamide,4
exercise training,4
oxygen,4
oxygen therapy,4
electronic health record review,4
nitric oxide,4
hyperbaric oxygen,4
covid-19 rt-pcr,4
behavioral intervention,4
transcranial direct current stimulation,4
best supportive care,4
ivermectin tablets,4
ecg,4
naltrexone,4
cvncov vaccine,4
serological test,4
allocetra-ots,4
normal saline (0.9% sodium chloride solution) - stage 1,4
unfractionated heparin,4
inactivated sars-cov-2 vaccine (vero cell),4
colchicine tablets,4
apixaban,4
pirfenidone,4
acalabrutinib,4
matching placebo,4
phone call,4
doxycycline,4
eculizumab,4
ensovibep,3
data record,3
av-covid-19,3
abatacept,3
ayurveda,3
surgery,3
ino-4800,3
cyclosporine,3
dzif-10c,3
eidd-2801,3
ofatumumab,3
convalescent plasma (cp),3
covid-19 serology,3
hydroxychloroquine sulfate 200 mg,3
surgical mask,3
slv213,3
selinexor,3
fostamatinib,3
apixaban 2.5 mg,3
methylprednisolone sodium succinate,3
sodium bicarbonate,3
ub-612,3
yoga,3
non-interventional,3
hydroxychloroquine and azithromycin,3
ty027,3
cannabidiol,3
nitric oxide gas,3
experimental group,3
hyperimmune plasma,3
supportive care,3
sars-cov-2 vaccine,3
sars-cov-2 serology,3
exhaled breath sampling,3
telmisartan,3
plasma,3
recombinant new coronavirus vaccine (cho cells) placebo group,3
ibrutinib,3
colchicine 0.5 mg,3
hzvsf-v13,3
avigan 200 mg film tablets,3
placebo intravenous,3
brii-196 and brii-198,3
sng001,3
ribavirin,3
coviage,3
resveratrol,3
exercise capacity,3
snpp protoporphyrin plus sunlight exposure,3
hyperbaric oxygen therapy,3
vitamin super b-complex,3
convalescent plasma transfusion,3
nasal swab,3
quercetin,3
prospective study with two measurement points investigating the impact of viral mitigation protocols on mental health,3
blood donation sms,3
placebo inhalation,3
mindfulness based intervention,3
placebo oral capsule,3
canakinumab,3
low dose radiation therapy,3
lanadelumab,3
clopidogrel,3
3d telemedicine,3
atorvastatin,3
pulmozyme,3
remdesivir placebo,3
ace inhibitor,3
peginterferon lambda-1a,3
mri,3
placebo (normal saline solution),3
blood collection,3
therapeutic anticoagulation,3
clinical examination,3
splenic ultrasound,3
clinical data,3
clinical assessment,3
mesenchymal stem cell,3
povidone-iodine nasal spray and gargle,3
chloroquine phosphate,3
acetylsalicylic acid,3
peripheral blood draw,3
niclosamide oral tablet,3
comparator,3
mesenchymal stem cells,3
bnt162b1,3
rehabilitation,3
acupressure,3
moderna covid-19 vaccine,3
vpm1002,3
rad26-s,3
distilled water,3
ly3832479,3
interleukin-7,3
remestemcel-l,3
lenzilumab,3
sars-cov-2,3
n-acetyl cysteine,3
bcg-denmark,3
low molecular weight heparin,3
corticosteroid,3
ag0302-covid19,3
suspension of heat killed (autoclaved) mycobacterium w,3
exposure,3
probiotic,3
fisetin,3
methotrexate,3
ct-scan,3
hydrocortisone,3
chadox1 ncov-19,3
ravulizumab,3
self-administered questionnaire,3
aerosolized 13 cis retinoic acid,3
at-527,3
biological sample collection,3
phase 2,3
self supportive care (ssc) alone,3
pcr,3
leronlimab (700mg),3
indicators of central sensitisation,2
sars-cov2 infection,2
biological samples,2
biosensor,2
sars-cov-2 virus,2
blood collection on admission and longitudinally,2
elispot,2
blood collection on their first consultation and 10 to 14 days later,2
rapid diagnostic test vs pcr,2
sars-cov2 testing,2
covid-19 exposure,2
tele-yoga therapy,2
olokizumab 64 mg,2
information,2
plx-pad,2
covid-19 test referral,2
biological data,2
sars-cov-2 inactivated vaccine,2
bbv152,2
nors (nitric oxide releasing solution),2
medium dosage inactivated sars-cov-2 vaccine on a 0- and 28-day schedule,2
basic treatment,2
sars-cov-2 diagnostic rapid test,2
medium dosage inactivated sars-cov-2 vaccine,2
baricitinib oral tablet,2
therapeutic plasma exchange (tpe),2
covid19,2
normal saline 0.9%,2
whole exome sequencing,2
normal saline (0.9% sodium chloride solution)- stage 2,2
2d telemedicine,2
covid19 vaccine,2
this is an online survey with no intervention.,2
file scanning,2
bacille calmette-guérin (bcg),2
practice details,2
azithromycin tablets,2
prayer,2
intramuscular vaccine,2
throat swab,2
meditation (1 x 20-minute guided audio training),2
thymalfasin,2
fear of covid-19 scale,2
awake proning,2
awake prone positioning,2
covid-19+ observational,2
sars-cov-2 mrna vaccine,2
covid-19 infection,2
fit test,2
telerehabilitation-based,2
xav-19,2
covid-19 patients,2
follow up,2
binaxnow rapid antigen system,2
poly-iclc (hiltonol®) or placebo,2
bicalutamide 150 mg oral tablet,2
bi 767551 intravenous,2
ec-18,2
bevacizumab injection,2
ebselen,2
fluoxetine,2
covid-19 self-test,2
best standard of care,2
best available treatment,2
covid-19 standard of care,2
covid-19 survey,2
bemiparin,2
flow cytometric analysis,2
covid-19 test,2
fuzheng huayu tablet,2
sars-cov-2 pcr,2
thalidomide,2
covid-19 therapeutic biologics - spike-gm-csf protein lactated ringer's injection,2
nowdx covid-19 test,2
vla2001,2
novaferon,2
td-0903,2
recombinant new coronavirus vaccine (cho cell) low-dose group,2
elisa,2
human amniotic fluid,2
sputnik light,2
hb-admscs,2
honey,2
hormones,2
pentoxifylline,2
gx-i7,2
gx-19n,2
standard care therapy,2
sevoflurane,2
standard covid-19 care,2
concert,2
services as usual,2
guduchi ghan vati,2
pcr test,2
chloroquine sulfate,2
conjunctival swab,2
human immunoglobulin,2
serum testing,2
hydrogen peroxide,2
cenicriviroc,2
patient-reported online questionnaire on olfactory & taste disturbances,2
metformin glycinate,2
zinc gluconate,2
serology test for covid-19,2
serology test,2
hydroxychloroquine - daily dosing,2
hydroxychloroquine - weekly dosing,2
hydroxychloroquine 200 mg oral tablet,2
chloroquine diphosphate,2
home exercise program,2
imu-838,2
physiotherapy,2
physical examination,2
hfnc,2
cohort,2
high dosage inactivated sars-cov-2 vaccine,2
high dosage inactivated sars-cov-2 vaccine on a 0- and 28-day schedule,2
soc + placebo,2
heparin sodium,2
high flow nasal cannula (hfnc),2
collection of biological samples,2
sivomixx (200 billion),2
high intensity interval training,2
phone call interview,2
sofosbuvir,2
phase 1,2
silmitasertib,2
sirolimus,2
sofosbuvir/daclatasvir,2
clevudine,2
comirnaty,2
single dose of hydroxychloroquine,2
simvastatin,2
simple cognitive task intervention,2
health supplements,2
radiation therapy,2
placebo (0.9% normal saline),2
ciclesonide,2
silymarin,2
siltuximab,2
metformin,2
carrimycin,2
mindfulness,2
breath test,2
icosapent ethyl,2
conventional treatment,2
non interventional study,2
icu treatment,2
placebo on a 0- and 28-day schedule,2
brii-196/brii-198,2
semi-directive interview,2
0.9%sodium chloride,2
coronary angiography,2
education,2
brequinar,2
edp1815,2
breathing exercise,2
coronovac vaccine,2
placebo control,2
breath biopsy face masks with removable filters and fitted pva strip,2
bovine lactoferrin,2
placebo vaccine,2
ophthalmologic exam,2
covi-drops,2
electronic questionnaire,2
online questionnaires,2
tacrolimus,2
immunological profiling,2
100 mg/ml virazole,2
meplazumab for injection,2
"taking blood samples (capillary and venous), saliva sampling and nasopharyngeal sampling.",2
covid convalescent plasma,2
conventional oxygen therapy,2
bronchoalveolar lavage,2
bucillamine,2
seraph 100,2
serological testing,2
standard treatment for covid-19,2
cardiopulmonary exercise test,2
control treatment schedule,2
cardiac surgery,2
hydroxychloroquine sulfate 200 mg [plaquenil],2
convalescent anti-sars-cov-2 mbt plasma,2
cardiac magnetic resonance,2
stc3141,2
cardiac and electrodermal recordings,2
grad-cov2,2
stellate ganglion block,2
paracetamol,2
hydroxychloroquine sulfate loading dose,2
hydroxychloroquine sulfate regular dose,2
hydroxychloroquine sulfate tablets,2
convalescent covid 19 plasma,2
convalescent plasma (anti-sars-cov-2 plasma),2
canine odor detection of volatile organic compounds,2
placebo group,2
convalescent plasma from covid-19 donors,2
camostat mesylate,2
glycine,2
hyperbaric oxygen therapy (hbot),2
stress levels and mental well-being assessment,2
hyperimmune immunoglobulin to sars-cov-2 (hivig),2
c21,2
300 mg of omega3-fa,2
early-dexamethasone,2
physical exercise,2
ivig,2
aeonose,2
aerobic exercise training,2
nicotinamide riboside,2
nicotinamide,2
muscle ultrasound,2
arbidol,2
arb,2
web based survey,2
aerosol box,2
veru-111,2
trv027,2
apremilast,2
pulmonary function tests,2
venous ultrasound,2
lactoferrin,2
expressive writing,2
routine care for covid-19 patients,2
appendectomy,2
prone positioning (pp),2
pulmonary function test,2
pul-042 inhalation solution,2
vehicle control,2
reparixin,2
pulmonary ultrasound,2
epivaccorona (epivaccorona vaccine based on peptide antigens for the prevention of covid-19),2
daclatasvir,2
kb109 + self supportive care (ssc),2
duvelisib,2
transcranial direct-current stimulation,2
lung ultrasound (lus),2
4c mortality score,2
vv-ecmo + cytokine adsorption (cytosorb adsorber),2
pyronaridine-artesunate,2
sab-185,2
cyproheptadine hydrochloride 4 mg,2
cyt107,2
vv-ecmo only (no cytokine adsorption),2
additional biological samples,2
l-citrulline,2
ruxolitinib oral tablet,2
ketogenic diet,2
adg20,2
ruti® vaccine,2
ruconest,2
lucira covid-19 all-in-one test kit,2
pulse oximeter,2
rtb101,2
nintedanib,2
l-ascorbic acid,2
ag0301-covid19,2
50 mg/ml virazole,2
mw33 injection,2
angiotensin converting enzyme inhibitor,2
nanocovax,2
dexamethasone injection,2
alteplase 50 mg [activase],2
uvc irradiation,2
exo 2 inhalation,2
angiotensin-(1-7),2
deferoxamine,2
lopinavir/ ritonavir,2
defibrotide,2
exo 1 inhalation,2
lopinavir-ritonavir,2
99mtc-pertechnetate aerosol,2
angiotensin 1-7,2
ambrisentan,2
nasopharyngeal swabs,2
retrospective data collection,2
nasal spray,2
recombinant covid-19 vaccine (sf9 cells),2
retrospective analysis,2
exercise group,2
exercise brochure,2
6-minute walk test,2
risk factors,2
tinzaparin,2
mw33 injection placebo,2
low dosage inactivated sars-cov-2 vaccine on a 0- and 28-day schedule,2
neuromuscular electrical stimulation,2
antithrombin iii,2
"two doses of low dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",2
"two doses of medium dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",2
resistance exercise,2
diagnostic test,2
leflunomide,2
diagnostic laboratory biomarker analysis,2
neurocognitive assessment,2
leronlimab,2
data collection and clinical testing of subjects,2
data extraction from medical files,2
antibody test,2
"resp301, a nitric oxide generating solution",2
"two doses of placebo at the schedule of day 0,28",2
txa127,2
rivaroxaban 10 mg,2
levamisole and isoprinosine,2
6 minute walk test,2
nacl,2
anti-sars-cov-2 human convalescent plasma,2
molnupiravir,2
nitrogen gas,2
exercise & nutrition,2
tranexamic acid,2
ion mobility spectrometry (ims),2
double-trunk mask,2
saline solution,2
saline placebo,2
probiotics,2
favipiravir placebo,2
crizanlizumab,2
matched placebo,2
isoquercetin,2
volatile organic compounds analysis,2
mout-to-mouth ventilation with quantitative analysis,2
iodine complex,2
disulfiram,2
mout-to-mouth ventilation,2
dwj1248,2
sample collection,2
doxycycline tablets,2
acebilustat,2
abidol hydrochloride,2
tofacitinib 10 mg,2
ct-p59,2
dose of tinzaparin or dalteparin,2
tocilizumab (tcz),2
saliva samples,2
maltodextrin,2
attention placebo,2
no interventions,2
saliva sample collection,2
recop unit patient,2
dornase alfa inhalation solution [pulmozyme],2
ct scan,2
quality of life,2
montelukast,2
"magpro x100 stimulator, b70 fluid-cooled coil",2
tocilizumab injection,2
recommended treatment schedule,2
ivermectin and doxycycline,2
no intervention (retrospective cohort observational),2
m5049,2
avigan,2
mrna-1273.351,2
ivermectin oral product,2
pregnant women with laboratory-confirmed 2019-n-cov,2
msc,2
ivermectin pill,2
endotracheal intubation,2
non,2
avdoralimab,2
non applicable,2
acute kidney injury,2
assessment of behavioral response to emotional stimulation,2
vv-ecmo,2
nivolumab,2
recombinant new coronavirus vaccine (cho cells) high-dose group,2
regn10933+regn10987,2
enoxaparin 40 mg/0.4 ml injectable solution,2
cvncov,2
assessment of work-related stress,2
autopsy,2
psychological assessment,1
psychological and physical rehabilitation based humanistic care,1
pt pal,1
pt-pal,1
questionnaires covid-,1
quinquina-stevia/azythromycin,1
questionnaires and neuropsychological assessment,1
questionnaires family,1
placebo control + best supportive care,1
placebo hydroxychloroquine,1
placebo control (non-behavioral infographic),1
physiological irrigating solution,1
physical exercises,1
quasistatic pressure-volume curve,1
placebo ec-18,1
psychological and behaviour change support,1
quality of life assessment,1
physiological saline solution,1
questionnaires covid+,1
pt-pcr test for sars-cov-2,1
quality of life promotion,1
physiological serum,1
questionnaires for specific phobia,1
quality of life questionnaires,1
quality of live assessment,1
placebo comparator: dw-ns,1
placebo for hydroxychloroquine,1
pt-x and imt,1
placebo daclatasvir 60 mg,1
placebo empty capsule,1
psychological stress and adaptation at work score (psas),1
physical exercise training,1
placebo for camostat mesilate,1
placebo for inhalation,1
psychological support,1
quantitative analysis for professionals,1
psychological treatment,1
quantitative analysis for patients,1
psychoeducational intervention,1
physical therapy,1
placebo gel,1
psychological triaging intervention,1
placebo granules,1
psychometric scale administration,1
psychoeducation,1
placebo for azithromycin,1
physiological effects of awake prone position in covid 19 patients,1
placebo for abbv-47d11,1
quantiferon,1
placebo for abbv-2b04,1
physical therapy exercise,1
physical therapy that include a standardized cycling training with functional electrical stimulation,1
psycho-social questionnaire,1
quantra system,1
psycho-education video,1
physical therapy that include a standardized cycling training with no additional functional electrical stimulation,1
quantitative antibody tests,1
psycho-education,1
"placebo for ""deficiency of qi and yang""",1
psychological and sociological interviews,1
"placebo for ""deficiency of qi and yin""",1
questionnaires on psychological quality of life,1
ptc299,1
ptsd,1
purapo,1
placebo (methylcellulose) capsule,1
pulse oximetry,1
placebo (oral tablet),1
qazcovid-in® - covid-19 inactivated vaccine,1
piperacillin/tazobactam,1
placebo (pbo),1
placebo (plasma-lyte 148),1
pulmozyme/ recombinant human deoxyribonuclease (rh-dnase),1
placebo (potato starch and magnesium stearate),1
piperacillin-tazobactam,1
placebo (saline),1
qazcovid-in®-vaccine against covid-19,1
placebo (sc injections),1
quercetin phytosome,1
quetiapine,1
pulmonary vascular permeability index,1
pioglitazone 45 mg,1
"placebo (sodium chloride bufus, solvent for the preparation of dosage forms for injection 0.9%)",1
placebo (iv),1
purclo,1
purinf,1
pwv,1
placebo (1 tablet daily during 60 days) + personal protective equipment (ppe),1
placebo (carrier control),1
pyronaridine-artesunate (pa),1
placebo (crossover vaccination period),1
q-nrg metobolic cart device,1
placebo (hartmann plus albumine),1
pyridostigmine bromide,1
placebo (human albumin 1%),1
quantitative analysis of anti-sars-cov-2-antibodies,1
placebo (initial vaccination period),1
purwet,1
quetionnary,1
placebo (im),1
q16 testing,1
placebo (inhaled solution),1
pk test,1
pitavastatin,1
purphl,1
pioglitazone 30 mg,1
pulmonary telerehabilitation,1
qrt-pcr and serology,1
public space exposure,1
placebo 0.10 mg + 1.00 mg/kg,1
placebo 0.20 mg + 2.00 mg/kg,1
placebo 0.9% nacl solution,1
placebo 1,1
pulmonary anomalies 4 months after documented covid-19 pneumonia,1
placebo 2,1
pulmonary and motor rehabilitation,1
placebo 250 cc 24 hours continuous infusion for 15 days,1
quidel sofia sars antigen fia,1
qualitative interviews (in 40 patients : 20 with covid-19 and 20 without covid-19),1
physiology,1
placebo atazanavir,1
placebo booster,1
public health england gold standard,1
ptx-covid19-b,1
ptsd check list (pcl) scale,1
physiological testing,1
placebo comparator: dw-ni,1
placebo - starch powder soft gels,1
piclidenoson,1
"placebo (sodium chloride, a 0.9% solution for the preparation of dosage forms for injections)",1
"questionnaires, spirometry",1
pioglitazone,1
"placebo (two doses), priming",1
placebo + soc,1
pulmonary tele-rehabilitation,1
placebo + vitamin d,1
quadramune(tm),1
questionnary,1
quantitative and qualitative assessments of mental health,1
quadrivalent influenza vaccine (qiv),1
qualitative and quantitative virus pcr of respiratory secretions in patients with high aerosol concentrations,1
pilot a rapid sars-cov-2 testing strategy,1
questionnaires patient,1
pilates exercises,1
pulmonary physiotherapy techniques,1
pulmonary function tests (pft),1
placebo - phase i,1
qualitative analysis for professionals,1
pulmonary function testing,1
quantitative analysis of sars-cov-2 antibodies,1
pregnant women under investigation for coronavirus or diagnosed with covid-19,1
psychiatric counseling,1
positive for sars-cov-2 infection,1
polymorphism of the hsd3b1,1
polyoxidonium,1
pool lamp,1
pool rt-pcr,1
progressive cycling exercise test to exhaustion,1
poractant alfa,1
prognostic score,1
positive covid test result - hypothetical scenario,1
progesterone 200 mg oral capsule,1
questionnaire for evaluation of confinement on deviant sexual fantasies,1
positive feedback,1
positive psychology (pp) exercises,1
placebo inhaled,1
progesterone 100 mg,1
positive psychotherapy,1
post covid-19 functional satus scale,1
produce prescription program,1
post traumatic stress disorder questionnaire (ptsd-8),1
questionnair about emerging legal and ehical disputes over patient confidentiality,1
procedure : multimodal microvascular assessment at study inclusion,1
"post traumatic, anxiety and depression evaluation",1
problem-solving and relationship improvement intervention.,1
post-intensive care unit syndrome,1
postpartum women under investigation for coronavirus or diagnosed with covid-19,1
polymerase chain reaction (pcr) test,1
questionnaire forms,1
progressive muscle relaxation,1
point-of-care ultrasonography (pocus),1
plitidepsin 1.5 mg/day,1
plitidepsin 2.0 mg/day,1
plitidepsin 2.5 mg/day,1
pln-74809,1
pneumococcal vaccine,1
promotores de salud,1
prolonged proned positioning,1
prolonged exposure therapy,1
pneumoniacheck,1
poc covidx™ rapid antigen test,1
poc sars-cov-2 igg antibody test,1
poct,1
point of care testing device for c-reactive protein,1
questionaire,1
"questionnaire including validated tools such as patient health questionnaire (phq-9), the 7-item generalised anxiety disorder (gad- 7), the 7-item insomnia severity index",1
questionaire to husband and wife,1
prolectin-m; a (1-6)-alpha-d-mannopyranose class,1
prolastin,1
"point of care ultrasound including echocardiography, lung ultrasound, vascular ultrasound",1
point-of-care rapid anti-sars-cov-2 antibody test (orient gene biotech) and dry blood spot collection (euroimmun),1
project echo,1
progressive muscle relaxation training,1
point-of-care test for sars-cov-2,1
questionnaire filling,1
questionnaire completion,1
problem solving therapy (pst).,1
press needles,1
power breathe,1
preservision areds formulation soft gels or tablets,1
prasugrel,1
questionnaire and optional interview,1
preservative-free saline,1
prasugrel hydrochloride 10 mg oral tablet,1
prazosin,1
pre-operative screening,1
pre_dinner yoga-based breathing support,1
pre_lunch yoga-based breathing support,1
questionnaire and interview,1
"predict admission of covid-19 patients to icu and death with routine and quickly avalaible clinical, biological and radiological variables?",1
prediction market,1
"questionnaire administration,blood sampling and genetic analyses.",1
physical exercise and computerized cognitive training,1
predictive factors for clinical response in patients with covid-19.,1
predictors adverse evolution,1
presence of specific anti-sars-cov-2 antibodies,1
premier biotech covid-19 igg/igm rapid test cassette,1
predictors of health care provide,1
prednisolone,1
prednisolone 5 mg,1
prednisone tablet,1
povidone-iodine solution 1.25% w/w [0.125% available iodine] usp,1
prevalence of covid-19,1
postural positioning,1
preventive information,1
questionnaire collection,1
problem management plus,1
povidine iodine nasal swabs,1
probiotics (2 strains 10x10^9 ufc),1
probiorinse,1
pro-sero-cov,1
"pro bnp , vitamin d",1
primepro™/ primemsk™,1
primepro,1
povidone-iodine 0.4% ni,1
povidone-iodine 0.5%,1
primary exposure status of pfizer-biontech covid-19 vaccine,1
povidone-iodine 0.5% ni,1
questionnaire by phone call,1
primary exposure is hypoxia (no intervention),1
povidone-iodine 0.5% ns,1
questionnaire : preparedness for caregiving scale,1
"primary care professionals reports of potential patient safety incidents, non-covid-19 related",1
povidone-iodine 0.6% ni,1
povidone-iodine 0.6% ns,1
povidone-iodine 2%,1
primary care,1
previfenon®,1
plitidepsin,1
plethysmography & dlco,1
questionnaire survey,1
prospective study across two time-points examining the impact of viral mitigation protocols on mental health,1
placebo oral solution,1
prospective observation,1
prospective oberservational registry,1
placebo patch,1
prospective cohort in high body mass index patient with covid 19,1
placebo plain water mouth rinse arm,1
placebo plus standard preventive measures,1
placebo pmdi,1
prospective chart review,1
quercetin phytosome (qp),1
placebo ribavirin,1
placebo rinse,1
placebo saline,1
placebo single,1
placebo sofusbuvir + daclatasvir 60 mg,1
placebo solution,1
placebo spray,1
placebo starch,1
placebo subcutaneous solution,1
placebo tablet,1
prosocial-benefit,1
placebo therapy,1
placebo to match rdv,1
placebo oral capsule; from august 2020 'no additional treatment',1
prospective study with two measurement points investigating the impact of viral mitigation protocols on parental burnout,1
placebo with remdesivir,1
placebo oral,1
pss (perceived stress scale),1
psqi,1
placebo injection and placebo pill,1
psg,1
placebo magnesium,1
placebo mini drinks,1
placebo multiple,1
psc-04,1
placebo nebuliser solution,1
placebo nitazoxanide,1
proxalutamide (gt0918),1
placebo of excipient(s) will be administered,1
placebo of fx06,1
placebo of hydroxychloroquine,1
placebo of lpv/r tablets,1
placebo of nicotine transdermal patch,1
placebo oil,1
placebo on a 0- and 14-day schedule,1
protrans®,1
prototype swab,1
protocolised mechanical ventilation strategy,1
prothione™ (6g),1
protective ventilation,1
placebo videos,1
placebo without radiofrequency.,1
prone,1
placenta-derived mmscs; cryopreserved placenta-derived multipotent mesenchymal stromal cells,1
plaquenil 200mg tablet,1
plasebo acupressure,1
plasma donation,1
plasma exchange,1
plasma exchange and convalescent plasma,1
prone position ventilation,1
prone position group,1
questionnaire with precaution information,1
plasma expansion with ringer's acetate,1
plasma from a volunteer donor,1
prone position (pp),1
plasma from convalescent patients with covid-19,1
querying the insee database,1
plasma from covid-19 convalescent patient,1
plasma hyperimmune,1
plasma igg levels,1
plasma sampling,1
plasma therapy using convalescent plasma with antibody against sars-cov-2,1
prone lying position,1
"platelet count, platelet, mean platelet volume and platelet distribution width in covid-19",1
quesionnair,1
prone decubitus,1
pleth variability index,1
plant stanol mini drinks,1
quercetin treatment,1
placebo- 0.10 mg/kg,1
"questionnaire, phone call",1
placebo- 0.20 mg/kg,1
placebo- 1.00 mg/kg,1
quercetin prophylaxis,1
placebo- 2.00 mg/kg,1
prosocial acts,1
proprietary extract of nerium oleander,1
propranolol hydrochloride,1
placebo-lde phase 2,1
propolis,1
placebo-simulation of transcranial direct current stimulation,1
propofol,1
placebo/aluminum adjuvant of inactivated sars-cov-2 vaccine,1
prophylaxis,1
questionnaire-based observational study,1
prophylactic/intermediate dose enoxaparin,1
prophylactic lactoferrin daily,1
placebo/control,1
placebo: emtricitabine/tenofovir disoproxil placebo,1
placebo: hydroxychloroquine,1
prophylactic heparin,1
proper diet,1
placebo; 0.9% saline,1
"questionnaire, same tools as before, with inclusion of pcl5 questionnaire too.",1
placebo pbmt/smf,1
pacritinib,1
physical and cognitive activity,1
nebulized saline,1
netosis markers,1
nestacell®,1
neonatal resuscitation without ppe for the prevention of sars-cov-2 infection,1
neonatal resuscitation with ppe for the prevention of sars-cov-2 infection,1
negative covid test result - hypothetical scenario,1
negative control,1
nebulized sterile saline,1
nebulized platelet lysate,1
neuro +,1
nebulized furosemide,1
nebulized administration of zyesami™ or placebo,1
nebulised unfractionated heparin (ufh),1
nebulised recombinant tissue-plasminogen activator (rt-pa) - cohort 2 niv,1
nebulised recombinant tissue-plasminogen activator (rt-pa) - cohort 2 imv,1
nebulised recombinant tissue-plasminogen activator (rt-pa) - cohort 1,1
nebulised heparin,1
neural network diagnosis algorithm,1
neuro -,1
niagen,1
new qiastat-dx fully automatic multiple pcr detection platform,1
ngm621,1
ng test,1
next generation sequencing (ngs) analysis,1
newsfeed function,1
news score,1
newborns from covid 19 positive mothers,1
new screening strategy,1
new ppe,1
neuroimaging findings in patients with covid-19,1
neutralizing antibodies,1
neutralization assay,1
neutral writing control,1
neuropsychological assessment,1
neuromuscular evaluation,1
neuromuscular blocking agents,1
neurology test,1
ndv-hxp-s vaccine,1
"ncapp, a cell phone-based auto-diagnosis system",1
nbt-nm108,1
nasafytol®,1
naser al-husban,1
nasal spray containing anti-sars-cov-2 antibodies derived from bovine colostrum,1
nasal pharyngeal (np) swab samples,1
nasal lavage,1
nasal irrigation,1
nasal dexamethasone,1
nasal brushing,1
narsoplimab,1
nbp2001 adjuvanted with alum (rbd 50μg/dose),1
narrow band ultraviolet b-band light,1
narrative writing,1
nanomix elab® covid-19 rapid antigen panel (non-interventional),1
nangibotide,1
naltrexone hydrochloride,1
nafamostat mesylate,1
nad+,1
nasopharyngeal (np) swab,1
nasopharyngeal and throat swab,1
nasopharyngeal and throat/oropharyngeal swabs analyses by rt-pcr and ddpcr,1
nasopharyngeal covid 19 rt-pcr,1
nbp2001 adjuvanted with alum (rbd 30μg/dose),1
nbi images and/or videos,1
navigation services,1
nature+mindfulness,1
nature only,1
natural killer cells infusion,1
natural honey,1
nasovax,1
"nasopharyngeal, oropharyngeal, or saliva swab",1
nasopharyngeal swabbing procedure (self swabbing first),1
nasopharyngeal swabbing procedure (conventionnal swabbing first),1
nasopharyngeal swab for covid-19 testing,1
nasopharyngeal swab and main laboratory,1
nasopharyngeal sampling,1
nasopharyngeal samples,1
nhanes smell and taste tests,1
niclosamide + camostat,1
physical activity program,1
no intervention-mechanistic study,1
no interverntion,1
no interventions planned,1
"no interventions performed. just collecting data, blood samples and post-mortem biopsies.",1
no interventional study,1
no intervention; observational study,1
no intervention. observational cohort study,1
no intervention. method study. psychometric testing,1
"no intervention, this is an observational study that uses validated questionnaires and qualitative interviews..",1
no message,1
"no intervention, observational",1
"no intervention, observation only",1
"no intervention will be administered, this is a retrospective observational study.",1
no intervention planned due to the observational study design only a diagnostic testing,1
no intervention planned due to the observational study design - only a diagnostic testing,1
no intervention performed,1
no intervention on patients,1
no intervetion will be used,1
no messaging,1
niclosamide suspension,1
noa-001,1
non-contact magnetically-controlled capsule endoscopy,1
non-contact ecg,1
non-cardiac surgery,1
non-acei/arb,1
non narrow band ultraviolet b-band light,1
non invasive visual acuity testing,1
non intervention,1
no-immunosuppressive,1
no personal protective equipment (ppe),1
no video,1
no special intervention,1
no severe covid-19,1
no screening testing strategy,1
no rinsing,1
no research related technology based social interactions,1
no racial inequality highlighting,1
no intervention is planned,1
no intervention as it is an observational study,1
no intervention / evaluation of the ferritin and glycosylated ferritin by standard approved serological tests,1
nintedanib 150 mg [ofev],1
nitazoxanide tablets,1
nitazoxanide placebo,1
nitazoxanide and ciclésonide,1
nitazoxanide and atazanavir/ritonavir,1
nitazoxanide 500mg oral tablet,1
nitazoxanide 500 mg,1
nio® (intraosseous access),1
nintedanib 150 mg,1
no intervention / compare the difference in respiratory rate between h0 and h12 of the initiation of morphine between the control and interventional groups,1
nil intervention,1
nigella sativa seed,1
nigella sativa oil,1
nigella sativa / black cumin,1
nigella,1
nicotine patch,1
nicotine 7 mg/ 24h transdermal patch - 24 hour,1
nitrate-deplete beetroot juice,1
nitric oxide 0.5 % / nitrogen 99.5 % gas for inhalation,1
nitric oxide delivered via lungfit™ system,1
"nitric oxide lozenges, 30 mg",1
no intervention - quality of life measure,1
no intervention - exposure is to covid-19,1
no intervention (survey study for medical doctors).,1
no intervention (only interview),1
no activities of the hbcc project and also no soap (pure control),1
no active intervention (observational only),1
nk-1r antagonist,1
"nk cells,il15-nk cells,nkg2d car-nk cells,ace2 car-nk cells,nkg2d-ace2 car-nk cells",1
nk cells,1
ni̇cas,1
nivolumab injection,1
nitroglycerin,1
nitric oxide-sessions,1
nitric oxide-releasing drug,1
nitric oxide-continuous and sessions,1
nacl solution,1
nacl 0.9%,1
nac + bromhexine (bmx),1
moderate exercise training (age group 3; above 45 years),1
modified cariescare international management,1
modified bai he gu jin tang,1
modification of the planned therapeutic management,1
moderna mrna-1273 vaccine,1
"moderna covid-19 vaccine, mrna-1273 (100 μg)",1
moderna,1
moderate intensity aerobic exercises,1
moderate exercise training (age group 2; 31 to 45 years),1
modified rankin score,1
moderate exercise training (age group 1; young adult 17 -30 years),1
model validation,1
model building,1
modafinil,1
mobile phone support,1
mobile mental health app - 4,1
mobile mental health app - 3,1
modified ipac-uhn ppe,1
molecular assessment of saliva,1
na-831and dexamethasone,1
monitoring physiological data with the hexoskin smart shirt,1
monthly serologic igm/g test,1
montelukast plus favicovir (favipiravir),1
montelukast oral tablet,1
montelukast 10mg,1
monitoring visit - week 8,1
monitoring visit - week 4,1
monitoring visit - baseline,1
monitoring of the immune response,1
molecular hydrogen,1
monitoring for aggravation,1
monalizumab,1
mon002,1
mometasone furoate nasal spray,1
molixan,1
molgramostim nebuliser solution,1
molecular testing for virus rna using rt-pcr,1
mobile mental health app - 2,1
mobile mental health app - 1,1
mobile internet survey on self-test,1
"micronized and ultra-micronized palmitoylethanolamide (mpea and umpea, 300mg + 600mg) oral suspension",1
mindfulness intervention,1
mindfulness based cognitive therapy for resilience during covid-19 plus chamindwell,1
mindfulness alone (mo) intervention,1
mindfulness + compassion intervention (mc),1
mindfullness based cognitive program,1
mind body syndrome therapy for long covid,1
microscopy of defined brain regions on autopsy specimens,1
"microcrystalline cellulose, nf",1
mmrc (modified medical research council) dyspnea scale,1
microcrystalline cellulose capsule,1
microcirculation recording,1
microcannula harvest adipose derived tissue stromal vascular fraction (tsvf),1
microbiome spray,1
microbiome immunity formula,1
mhealth platform,1
mhealth assessments,1
mindfulness program,1
mindfulness rounds,1
mindfulness session(s),1
mindfulness training,1
mmr vaccine,1
mls laser,1
mk-5475,1
"mixture 3,6% h2 in n2 (96.4%)",1
mitral valve surgery,1
minnrap peer support program,1
miniprobe alveoflex,1
minimal attention control intervention,1
mindrhythm harmony,1
mindfulness-sos for refugees,1
mindfulness-based stress reduction,1
mindfulness-based health promotion,1
mindfulness-based cognitive therapy,1
mindfulness training program,1
mindfulness training (mt) connect,1
montmorrillonite,1
morning yoga-based breathing support,1
mortality,1
multitest 6 color tbnk and bd lyotubes,1
museum virtual guided tours,1
musclesound ultrasound,1
muscle-target oral nutritional supplementation,1
muscle relaxation therapy,1
muscle relaxation,1
muscle biopsy,1
multivitamin with 11mg of zinc,1
multisystem inflammatory syndrome in children (mis-c),1
mucodentol,1
multistem,1
multiple doses of anti-sars-cov-2 convalescent plasma,1
multipeptide cocktail,1
multimodal teleprehabilitation,1
multifrequency bioimpedance spectroscopy,1
multiecco2r blood-gas exchanger,1
multicapillary column coupled ion mobility spectrometry,1
music therapy,1
mva-sars-2-s vaccinations (days 0 & 28),1
mva-sars-2-st,1
mvc-cov1901,1
na-831 and atazanavir,1
na-831,1
na (no intervention),1
n95 respirator,1
n95 mask,1
n/a - samples collected along routine care samples only,1
n-acetylcysteine (nac),1
n-acetyl glucosamine (nag),1
n-95 respirator,1
n-803,1
"n terminal pro b type natriuretic peptide (ntprobnp), d-dimer, and serum tropinin - i",1
mvc-cov1901(saline),1
mvc-cov1901(s protein with adjuvant),1
mvc-cov1901(mid-dose),1
mvc-cov1901 (high-dose),1
multi-omics,1
mstt1041a-matched placebo,1
motivation,1
mouthrinse without bêta-cyclodextrin and citrox,1
mr-pro-adm,1
mr or m-m-r ii ® vaccine,1
mpt0b640,1
moxifloxacin or levofloxacin,1
moxibustion plus cupping,1
mouthwashes and nose rinse in a conventional way,1
mouthwash and nose rinse with the agnps solution,1
mouthrinse with bêta-cyclodextrin and citrox,1
mstt1041a,1
"mouthpiece b1(mouthpiece mpc-st gmdn:62534 generic name: endoscopic bite block, basic, reusable",1
motivational telephone intervention,1
motivational social support from nurse with additional support from significant other,1
motivational social support from nurse,1
motivational messages,1
motivational interviewing and covid-19 symptom monitoring system,1
motivational interviewing,1
mrg-001,1
"mri (heart, brain, lungs, liver)",1
mri scans,1
mrna covd19 vaccine,1
msct,1
mscs-derived exosomes,1
mscs,1
msc-exosomes delivered intravenously every other day on an escalating dose: (2:4:8),1
msc-exosomes delivered intravenously every other day on an escalating dose (8:4:8),1
msc-exosomes delivered intravenously every other day (8:8:8),1
msc treatment,1
mrx-4dp0004,1
mrna-1283,1
mrna-1273.211,1
mrna-1273 vaccine,1
mrna-1273 sars-cov-2 vaccine from moderna,1
mrna-1273 sars-cov-2 vaccine,1
mrna in urine test,1
mrna covid-19 vaccine,1
non-contact mce system,1
non-convalescent fresh frozen plasma (standard plasma),1
non-convalescent plasma (control plasma),1
part a: upamostat 200 mg,1
passed infection of sars-cov-2,1
particle measurement,1
participate in a massive musical event,1
partially hla-matched sars-covsts,1
partial vepmp intervention,1
part b: upamostat 200 or 400 mg,1
part a: upamostat 400 mg,1
part a and b: placebo,1
"patch, nicotine",1
parentchat for parents of children ages 2-17,1
parent positive,1
paraclinical examination,1
pandemic period,1
pandemic control measures,1
pamrevlumab,1
palmitoylethanolamide,1
passive microwave radiometry,1
"patch, placebo",1
oral-b mouth sore mouthwash,1
patient quality of life assessment,1
patients covid 19,1
patients admitted to intensive care unit with sars-cov2,1
patients admitted in intensive care units,1
patient-centred advice on telephone consultation in tb patients:,1
patient with sar-cov-2 infection,1
patient status engine,1
patient sampling,1
patient mychart scheduling link,1
pathogen reduced sars-cov-2 convalescent plasma,1
patient management suffering of coronavirus infection,1
patient health questionnaire-9 (phq-9),1
patient health questionnaire (phq-9),1
patient educational video,1
patient education,1
patient characteristics,1
pathogen-specific aapc,1
race concordant,1
pacebo: calcium citrate,1
p2y12,1
oseltamivir 75mg,1
outpatient mri,1
otilimab,1
others(no intervention),1
other vaccine against sars-cov-2,1
ot-101,1
osteopathic manipulative treatment (omt),1
osoc,1
orthopaedic surgical procedures,1
p2et (caesalpinia spinosa extract),1
ortd-1 mid dose,1
ortd-1 low dose,1
ortd-1 high dose,1
oropharyngeal swabs,1
oropharyngeal swab,1
oropharyngeal and intestinal microbiota,1
orally suspension of cov2-ogen1,1
overcoming anxiety in pregnancy and postpartum online self-directed program,1
overnight intensive recovery / extended post anaesthetic care in pacu,1
ovotransferrin,1
oxaloacetate medical food/dietary supplement,1
ozonized oil (hoo,1
ozone auto-hemotherapy,1
ozanimod,1
oxytocin,1
oxyhydrogen,1
"oxygen-ozone therapy, probiotic supplementation and standard of care",1
oxygen treatment,1
oxygen supply,1
oxygen saturation monitoring,1
oxygen mask,1
oxygen hood,1
oxygen gas,1
oximen® 3%,1
oxidative stress elisa kit,1
oxford-astrazeneca covid-19 vaccine,1
patients received standard of care treatment during hospitalization,1
patients receiving nasal high flow,1
patients recovering from covid19 receive usual care by allied health professionals,1
pertuzumab and trastuzumab fixed-dose combination for subcutaneous administration (ph fdc sc),1
pfizer-biontech covid-19 vaccine,1
pfizer comirnaty vaccine,1
pfizer,1
pf-07321332/ritonavir,1
pf-07304814,1
pf-06650833,1
pet-ct of 18f-fdg,1
personalized health education,1
personal exercise intervention,1
personalized ambulatory training,1
personal risk messaging,1
personal protective testing booth,1
personal protective measures,1
personal protective equipment from biological hazard,1
personal protective equipment (ppe),1
personal protective equipment,1
pfizer-biontech covid-19 vaccine bnt162b2 (30 µg)( comirnaty®),1
phage therapy,1
phase 3 cardiac rehabilitation,1
philips lumify ultrasound system,1
physical activity level,1
physical activity counseling,1
physical activity,1
phsyiotherapy,1
phr160 spray,1
phq-9 depression scale,1
phq-9 (patient health questionnaire) depression scale,1
phq-9 (9-item patient health questionnaire),1
photobiomodulation and photodynamic therapy,1
phosphate-buffered saline,1
phone-call screening and management by a medical student/general practitioner tandem,1
phone-based monitoring,1
phone interviews,1
phone interview,1
phlebotomy,1
personal freedom message,1
personal behaviours,1
patients with hemopathy,1
pectin,1
pegylated interferon-α2b,1
pegylated interferon lambda,1
peginterferon lambda alfa-1a subcutaneous injection,1
peginterferon beta-1a,1
peer resilience champion,1
peer mentor delivery,1
peep trial,1
pealut,1
peroxyl,1
pdno,1
pd-1 blocking antibody+standard treatment,1
"pcr, lung ultrasound",1
pcr value,1
pcr for covid-19,1
pcl cov05 - covid 19 ag rapid fia test (rapid antigen test),1
patients with the treatment agains covid19,1
pembrolizumab (mk-3475),1
pemziviptadil (pb1046),1
pentaglobin,1
pentarlandir™ uppta,1
peripheral venous ultrasound,1
peripheral lymphocytes subsets,1
peripheral blood sampling,1
peripheral blood samples,1
peripheral blood,1
periogard,1
performing routine care (clinical and paraclinical tests),1
performing of lung ultrasound,1
performance of the test antigenic and test rt-pcr,1
performance evaluation study of realdetect rt-pcr kit for covid-19 detection,1
performance evaluation (sensitivity and specificity) for covid-19 diagnosis of the vocus ptr-tof process,1
percutaneous treatment,1
percutaneous coronary revascularization for stemi,1
perceived stress scale,1
pep flute,1
oral-b® gum & enamel care -cetylpyridinium chloride,1
oral supplement enriched in antioxidants,1
non-enhanced ct scan of the chest,1
nutrition consult and protein supplementation,1
obesity,1
nvx-cov2373,1
nuvastatic,1
nutritional support system (nss),1
nutritional intervention,1
nutritional assessment,1
nutrition support,1
nutrition,1
observation group 1,1
nusepin® 0.2 mg,1
nusepin® 0.1 mg,1
"nusapure standardized olive leaves capsule, 750 mg (50% oleuropein)",1
"nursing care to reduce anxiety, fear and loneliness",1
nurse-community-family partnership intervention,1
nudge,1
nt-i7,1
observation for study group,1
observation no intervention,1
oral polio vaccine + information,1
observational measurement of biometric data. no change to health care provided.,1
"obtainment of nasopharyngeal, oropharyngeal, buccal, nasal and saliva samples",1
obstetric anesthesia and analgesia,1
observational study: this registry data will provide more specific information about how people with blood cancer respond to covid-19 virus and/or a covid-19 vaccination.,1
observational study only,1
observational study - no intervention,1
observational only,1
observational of different courses of sars-cov-2 infection in different phases (acute vs. post-acute) and settings,1
observational cohort study on the natural history of hospitalized sars-cov-2 patients.,1
observation of behavior and covid-19 infection will be conducted.,1
observational (registry),1
observation to monitor patients for these infections,1
observation only,1
"observation of patients with known, suspected, or at risk for covid-19 infection",1
observation of different courses of sars-cov-2 infection in different phases (acute vs. post-acute) and settings,1
observation of covid 19 pneumonia,1
observation of breathing pattern,1
nricm101,1
np-120 (ifenprodil),1
nox66,1
non-ras blocking antihypertensives,1
noninvasive ventilation,1
"none, this study is observational",1
none - observational,1
none - na,1
none - descriptive study,1
none (observational study),1
none (not interventional),1
non-operative management,1
novel laser inferometry test for corona virus,1
non-mindfulness intervention,1
non-invasive ventilatory support,1
non-invasive ventilation strategies,1
non-invasive red lllt treatment to chest of patient.,1
non-invasive cardiac imaging,1
non-interventional study,1
non-hospitalization procedures,1
noninvasive ventilation treatment,1
nordell double e-100 layer mask,1
nordell single e-100 layer mask,1
normal saline infusion + standard of care,1
novel coronavirus infection,1
not required,1
not bravery message,1
"not applicable, this is an observational study",1
not applicable as observational study,1
not applicable (observational study),1
not applicable (na),1
nosocomial infection/hospital acquired infection,1
"normal saline solution (nss), placebo, day 21 - phase 2",1
"normal saline solution (nss), placebo, day 21 - phase 1",1
"normal saline solution (nss), placebo, day 189 - phase 2",1
"normal saline solution (nss), placebo - phase 2",1
"normal saline solution (nss), placebo - phase 1",1
normal saline placebo,1
normal saline intranasal,1
obvio-19 app,1
occupational health workers,1
octagam,1
online survey questionnaire,1
opt-in (call-back),1
ophtamesone,1
operative management,1
open label bss (pepto bismol),1
op-101,1
onsite point-of-care,1
only standard treatment,1
online survey about dietary and lifestyle habits,1
online intervention mental health covid-19,1
online support group,1
online social network and collective intelligence intervention,1
online self-help intervention,1
online questionnaire and interviews,1
online psychological intervention for healtchare workers,1
online mindfulness group,1
online lifestyle intervention,1
opt-in (in-bound),1
opt-in recruitment email,1
opt-out framing,1
opt-out recruitment email,1
oral ivermectin,1
oral intervention with cetylpyridinium chloride,1
oral fluid swab,1
oral co-trimoxazole,1
oral care with/without aerosolization,1
oral and nasal spray by distilled water to control group,1
oral administration of colchicine plus herbal phenolic monoterpene fractions,1
oral 25-hydroxyvitamin d3,1
oral 13 cis retinoic acid,1
oral,1
optional questionnaire completion,1
optional blood completion,1
optimized management of covid-19 positive kidney transplant recipients: single center experience from the middle east,1
optical coherence tomography angiography,1
optical coherence tomography (oct),1
online kkh sports singapore program with usual care,1
online intervention grief covid-19,1
octagam 10%,1
olfactometry,1
omalizumab,1
olo-1 medical molecular sieve oxygen generator,1
olfactory test,1
olfactory retraining,1
olfactory rehab,1
olfactory device,1
olfactory and gustatory tests,1
olfaction testing,1
online instruction,1
old ppe,1
"ol-1, standard dose",1
"ol-1, high dose",1
ointment and dressing for external use,1
off the shelf vr,1
odd/even birth year intervention groups,1
octaplas,1
omega 3 fatty acid,1
omega 3/nigella sativa oil,1
omega 3/nigella sativa oil/anise seed capsule,1
omega 3/nigella sativa oil/deglycyrrhizinated licorice,1
online cognitive stimulation therapy,1
online cognitive behavioral therapy (cbt),1
online bibliotherapy programme,1
one dose of bnt162b2 vaccine,1
one covid-19 vaccine candidate (tmv-083) administration - high dose,1
on-site testing (lumiradx),1
on-line survey,1
omnibiotic aad,1
omni-biotic pro vi 5,1
omeprazole 20mg,1
omegaven®,1
omega-3 fatty acid supplement,1
omega dha / epa,1
omega 3/nigella sativa oil/quinine pills,1
omega 3/nigella sativa oil/indian costus,1
raas inhibitor [continued standard of care],1
rhea health tone®,1
racial inequality highlighted,1
thoracic ct-scan,1
"three doses of placebo at the schedule of day 0, 14, 28 #high-dose group#",1
"three doses of middle-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14, 28",1
"three doses of high-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 14, 28",1
"three doses of high-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14, 28",1
thoraxic computed tomography,1
thorax ct,1
thoracic lung ultrasound,1
thoracic ct scan,1
"three doses of placebo at the schedule of day 0, 14, 28（high-dose group）",1
thoracic computed tomography scan,1
this study is not an intervention study,1
this study is non- interventional,1
thiazide or thiazide-like diuretics,1
thermography,1
there is no intervention in this study,1
there is no intervention,1
"three doses of placebo at the schedule of day 0, 14, 28 #middle-dose group#",1
threshold imt device,1
therapy group,1
thymosin+standard treatment,1
"tinzaparin, high dose prophylactic anticoagulation",1
tinzaparin or unfractionated heparin,1
time management & participation & the leisure time activity,1
tigerase® and best available care,1
tice® bcg (for intravesical use) bcg live strain of the bcg (merck) vaccine,1
ticagrelor,1
thyroidectomy,1
thymosin alpha 1,1
throat swab sample for measuring current infection with sars-cov-2,1
thymic peptides,1
thromboprophylaxis with low-molecular-weight heparin or fondaparinux,1
thromboprophylaxis,1
thromboprofylaxis protocol,1
thrombomodulin modified thrombin generation assay (tga-tm),1
thrombin generation test assay,1
thrombin generation assay (tga),1
therapy intervention,1
theraputic heparin,1
treated with hyperimmune plasma,1
text message content,1
the effects of covid 19 pandemic on the cardiovascular heath of children with autism spectrum disorder,1
"the drugs used before and during the pandemic, the patient's job status, physical activity conditions, pain status",1
"the demographic, clinical, laboratory, and instrumental data",1
"the covid-19 vaccines bnt162b2, mrna-1273 and chadox1",1
the control group will not receive hydroxychloroquine,1
thawed plasma,1
text messaging only,1
text material for psychoeducation and audio for relaxation techniques,1
"the pop02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:",1
tetrandrine,1
tetracycline hydrochloride 3%,1
testnpass,1
testis pathology samples,1
testing sensitivity for sars-cov-2 virus in symptomatic individuals,1
testing procedure for binding antibodies,1
testing of sars-cov-2 antibodies,1
the icp monitoring will be performed in a non-invasive method developed by brain4care,1
the prepare program,1
therapist guided e-therapy,1
the vie scope laryngoscope,1
therapeutic plasmaexchnage,1
therapeutic plasma exchange : 3 sessions in 3 consecutive days (day 1 to day 3),1
therapeutic exercise and education,1
therapeutic exercise,1
theram covid-19 rapid antigen test,1
theory-based messages,1
theophylline powder,1
the usual treatment,1
the psychosocial effects of covid-19 pandemic on dental professionals,1
the use of the mentalplus® digital game for assessment and rehabilitation of cognitive function after remission of the symptoms of covid-19,1
"the study evaluates all surgical patients operated, both elective scheduled and emergent cases",1
the study does not required,1
the standard therapy,1
the standard protocol only,1
the standard of care,1
the standard macintosh laryngoscope,1
"tinzaparin, low dose prophylactic anticoagulation",1
"tinzaparin,therapeutic anticoagulation",1
tirofiban injection,1
"training of youth, community health assistants and community health workers.",1
transcendental meditation (tm),1
transcendental meditation,1
trans sodium crocetinate,1
tranexamic acid tablets,1
tramadol,1
"training video on anxiety, fear and loneliness in the covid-19 environment.",1
training session adressing information and health literacy,1
training load,1
transcutaneous auricular vagus nerve stimulation,1
"training for awareness, resilience, and action (tara)",1
training clinicians in basic critical care and the management of severe covid-19 cases,1
traditional proning arm,1
traditional communication tools,1
traditional chinese medicine prescription,1
traditional antirheumatic drugs,1
tradipitant,1
transcendental meditation (tm) and experience resolution methodology (erm),1
transdermal estradiol gel,1
tissue plasminogen activator,1
transpulmonary thermodilution,1
treadmill test (bruce protocol),1
treadmill exercise,1
travelan otc,1
trauma-informed yoga video recording,1
trauma informed yoga,1
trauma informed psychotherapy,1
transthoracic echocardiogram (tte),1
transpulmonary pressure measurements,1
transfer package from ci therapy,1
transplant patient,1
transparent sheet,1
transparent mask,1
transitional online peer support group (n=20),1
transfusion of standard plasma.,1
transfusion of sars-cov-2 convalescent plasma.,1
transfusion of covid-19 convalescent plasma,1
tracheotomy,1
tracheostomy with aerosol box in covid-19 positive patients,1
tracheostomy,1
to assess for development of igg antibodies against sars-cov2,1
tocilizumab 20 mg/ml intravenous solution [actemra],1
tocilizumab 180 mg/ml,1
tocilizumab +/- ruxolitinib (stages 2b/3),1
tociliuzumab,1
tobacco use,1
to monitor the effectiveness of the single dose ad26.cov2.s covid-19 vaccine,1
to determine the prevalence of renal dysfunction in hospitalized children with covid19 in qatar.,1
tnkase,1
tracheal intubation and cardiopulmonary resuscitation,1
tm5614,1
tlrs activation measurement,1
tlc19 vehicle,1
tlc19,1
tl-895,1
tj003234,1
titanium blood test,1
tocilizumab 20 mg/ml intravenous solution [actemra]_#1,1
tocilizumab 20 mg/ml intravenous solution [actemra]_#1 (2 doses),1
tocilizumab 200 mg/10 ml (20 mg/ml) intraven vial (ml),1
tocilizumab and ruxolitinib (advanced stage 3),1
tr,1
tpa,1
tozinameran,1
toremifene,1
toraymyxin pmx-20r (pmx cartridge),1
topical steroids and cyclosporin-a,1
toothpaste with tin fluoride,1
toothpaste with sodium monofluorophosphate,1
toothpaste with sodium fluoride and zinc,1
tools development,1
tomeka®,1
tom's botanically bright peppermint,1
tof protocol,1
tocilizumab prefilled syringe,1
tocilizumab injection [actemra],1
testing for sars-cov-2 rna,1
testing for sars-cov-2 igm/igg,1
testing for sars-cov-2,1
suspected of covid-19 infection,1
symptom and exposure surveys,1
symprove (probiotic),1
sweat samples (covidog ancillary study),1
swallowing evaluation with the eat-10 and the volume-viscosity swallowing test (v-vst),1
swabbing of conjunctiva,1
swab,1
suspension or maintenance of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors,1
susceptibility to infection,1
symptomatic drugs,1
surveys and questionnaires,1
surveys,1
survey work,1
survey to assess post traumatic stress and anxiety at inclusion and 6 months later,1
survey research,1
survey of sars-cov-19 knowledge,1
survey of acceptability of the different self-samples.,1
symptom survey,1
symptomatic treatment (paracetamol or best symptomatic treatment based on doctor recommendations),1
tak-019,1
t-cell receptor (tcr) repertoire,1
tailored best practices,1
tafenoquine oral tablet,1
t89 capsule,1
t89,1
t3 solution for injection,1
t-detect™ sars-cov-2 assay,1
t-detect covid t-cell blood test,1
t regulatory cells,1
"symptomatology, treatment. daily activities and anxiety for cardiovascular patients survey (strata)",1
t memory cells and nk cells,1
systemic treatment,1
systemic indirect endovenous ozone therapy,1
systematic offer of nurse-driven sars-cov-2 screening combined with usual practice,1
synthetic neutralising antibodies,1
symptoms questionnare,1
symptoms entered into the covidx application,1
survey group,1
survey and questionnaire,1
surgical repair,1
sublingual micro-dose ketamine,1
supervised stretching and strengthening exercise,1
supervised exercise training protocol,1
"supar, c-reactive protein, ferritin, d-dimer, procalcitonin, interleukin-6, lactate dehydrogenase",1
sulodexide,1
sulfur hexafluoride lipid-type a microspheres,1
sulfonatoporphyrin(tpps) plus sunlight exposure.,1
sudarshan kriya yoga (sky),1
sublingual methylene blue,1
surgical procedures performed under general anesthesia,1
subacute rehabilitation,1
study questionnaire,1
study of the synthesis of antibodies directed against sars,1
study of immune-mediated mechanisms in patients tested positive for sars-cov-2,1
study group,1
study d,1
study c,1
supine position,1
supine positioning,1
support as usual,1
support treatment,1
surgical procedure for cancer,1
surgical facial mask,1
surgical face mask use only,1
"surgical face mask (vheal med co., ltd., istanbul, turkey)",1
"surgery: dynamic hip screw, hemiarthroplasty, hip replacement, intramedullary nail",1
surge index,1
surge capacity,1
surfactant assessment,1
surfactant,1
supportive trauma exposure preparation program,1
supportive tratment,1
supportive therapy ssi,1
supportive therapy,1
supportive services,1
supportive and symptomatic treatment,1
tailored recommendations,1
tak-671,1
tested for sars-cov-2 (regardless of the result),1
telepsychoeducation,1
telmisartan 20mg oral tablet,1
telestroke,1
telesimulation,1
telerehabilitation-based relaxation exercise group (eg),1
"telerehabilitation i̇ntervention, motor learning",1
telepsychoeducation without personalized videos,1
telepsychoeducation with personalized videos,1
telephonic medical visit,1
telmisartan 40mg oral tablet,1
telephonic interview during the italian lockdown.,1
telephone-based coaching,1
telephone survey,1
telephone interview,1
telephone follow-up,1
telephone consult,1
telemonitoring and teleorientation,1
telmisartan 40mg,1
telmisartan arm will receive 80 mg telmisartan twice daily plus standard care.,1
tak-671 placebo,1
tenofovir/ emtricitabine ( 300 mg / 200 mg daily during 60 days) + personal protective equipment (ppe),1
test: favipiravir 200 mg (loqular),1
test pcr,1
test group: experimental - uvc therapy applied,1
test for sars-cov-2,1
"test at home's proprietary ""lollipop"" buccal cavity swab",1
test,1
tensile strength,1
tenofovir disoproxyl fumarate 300 mg plus emtricitabine 200 mg oral tablet,1
telmisartan oral product,1
tenofovir disoproxyl fumarate 300 mg oral tablet,1
tenofovir disoproxil and emtricitabine,1
tenecteplase,1
ten-days oseltamivir,1
temporarily holding the raas inhibitor [intervention],1
tempol,1
tem-tpa,1
telemedicine visit,1
telemedicine to remote outpatient visit in bariatric patient,1
telemedicine consultation,1
taxifolin aqua,1
tear collection,1
tdr,1
td139,1
tcm prescriptions,1
tcc-covid mhealth solution,1
tcb008,1
tb006,1
tavr or savr,1
telehealth phone calls,1
taste and olfactory function evaluation,1
targeted wellness formula c™ sublingual drops - 1200mg - 30 ml (formula c),1
tape-software,1
tape face mask,1
tap water,1
taking biological samples,1
tak-919,1
tears swab,1
technology based social interactions,1
telacebec,1
tele-delivered psychological intervention,1
telehealth monitoring,1
telehealth coaching sessions,1
telehealth applications,1
telehealth,1
telegeriatric intervention,1
teleconsultation either by phone or by computer consultation. quantitative and qualitative approaches to analysis,1
teleconsultation either by phone or by computer consultation,1
teleconsultation,1
telecare group,1
tele-rheumatology,1
tele-pulmonary rehabilitation,1
tele-physiotherapy group,1
tele-medicine platform,1
tele-interventions related to diabetes management and mental well-being,1
tele-exergaming tablet,1
treamid,1
treatment and prophylaxis,1
study arm,1
vitamin d3 or placebo,1
vitis xtra forte©,1
vitamins and minerals,1
vitamins,1
vitamine d3 supplementation,1
vitamin k2/d,1
vitamin k2 in the form of menaquinone-7 (mk-7),1
vitamin e,1
"vitamin d3 50,000 iu",1
viusid,1
vitamin d3 (cholecalciferol),1
vitamin d supplementation in pregnant women,1
vitamin d supplementation,1
vitamin c/zinc,1
"vitamin c, vitamin b complex and zinc acetate",1
vitamin c tablets,1
vitamin c 500 mg oral tablet,1
vitros anti-sars-cov-2 igg test,1
viusid and asbrip,1
vitamin and trace elements,1
vçac,1
"wearable devices, saliva samples, survey measures",1
water without an elevated level of kelea,1
water (e) mouth rinse with the solution provided,1
water,1
washed microbiota transplantation,1
ward css,1
walk test,1
vxa-cov2-1,1
vivadiag™ covid-19 lgm/igg rapid test,1
vr for psychoeducation and relaxation,1
volunteer of tip-oa program,1
volatile organic compounds analysis in sweat (mass spectrometry),1
volatile organic compounds analysis (mass spectrometry),1
volatile organic compounds analysis (e-noses),1
voice symptom scale (voiss),1
voclosporin,1
vitamin b12,1
vitamin a supplement,1
treatment as usual,1
vir-7832,1
virological and serological tests,1
virgin coconut oil (vco),1
virgin coconut oil,1
viral vector vaccine,1
viral specific t-cells (vsts),1
viral sequence,1
viral culture,1
vir-7831 (gen2),1
virtual care and remote automated monitoring,1
vir-7831 (gen1),1
views and experiences of health care professionals working in intensive care units during the covid-19 pandemic,1
vielight rx plus,1
vie scope laryngoscopy,1
videofluoroscopy,1
videofluoroscopic swallowing study (vfss),1
video-based psychotherapy,1
"virtual assistant first, then human coach",1
virtual care at home,1
vitamin a,1
virtual-care cognitive behavioural therapy,1
vitaltalk communication skills training,1
vitalconnect vital sign patch,1
vital signs,1
vit-d 0.2 mg/ml oral solution [calcidol],1
vit d,1
visual analogue scale,1
viruxal oral and nasal spray,1
virtual village,1
virtual family-based treatment,1
virtual reality therapy first,1
virtual reality exposure therapy,1
virtual reality,1
virtual peer support platform,1
virtual individual cognitive simulation therapy,1
virtual group intervention,1
virtual group exercise,1
wearable medical device (empatica e4),1
wearing surgical face mask sprayed with hypertonic saline,1
web application users,1
yoga group,1
zilucoplan®,1
zilucoplan placebo,1
zilucoplan,1
zavegepant (bhv-3500),1
zaritt burden interview,1
zanubrutinib,1
yu-ping-feng formula,1
yinhu qingwen granula,1
zinc (zinc gluconate),1
yinhu qingwen decoction(low dose),1
yinhu qingwen decoction,1
yin hu qing wen granula(low does),1
xylocaine,1
xvr011,1
xuanfei baidu granules,1
xlear nasal spray,1
zinc (placebo),1
zinc (zinc gluconate) & vitamin d (cholecalciferol),1
web based questionnaire,1
zofintm,1
γ-globulin,1
β-hydroxy β-methyl butyrate (hmb) enriched amino acid,1
"ıt will be compared pain, sleep, fatigue, physical activity level and quality of life and questioning exercise habits before and after the covid-19 outbreak in patients with behçet and fmf.",1
zyil1 capsule,1
zyesami™ (aviptadil acetate),1
zyesami (aviptadil acetate),1
zotatifin,1
zofin,1
zinc acetate,1
zithromax oral product,1
zinc sulfate 220 mg,1
zinc sulfate,1
zinc picolinate placebo,1
zinc picolinate,1
zinc gluconate and ascorbic acid,1
zinc citrate,1
xiyanping injection,1
xiang-sha-liu-jun formula,1
"xiamen wiz biotech co., ltd. sars-cov-2 antigen rapid test",1
weight counseling,1
white sender in acknowledgement,1
wharton's jelly derived mesenchymal stem cells.,1
wfi water nebulization,1
wfi 5% glucose,1
wellness education,1
well-being assessment,1
weight-based dexamethasone dose,1
weekly assessment,1
xcel-umc-beta,1
weck-cel swab collection,1
webex physical activity program,1
web-based survey,1
web-based redcap survey,1
web-based psychosocial peer-to-peer support,1
web-application,1
web embolization,1
white sender in informational videos,1
who recommendations (waiting condition),1
whole genome analysis,1
whoqol-bref,1
xc7 200 mg single,1
xc7 200 mg multiple,1
xc7 100 mg single,1
xc221,1
written summary of rounds,1
written information,1
work requirement exemption months,1
wofb,1
woebot substance use disorder,1
wj-mscs,1
without masks,1
withings scanwatch,1
wingate exercise test and on-ice testing while wearing a sham face mask,1
wingate exercise test and on-ice testing while wearing a face mask,1
whoqol-bref survey,1
video-based intervention,1
video-based,1
video text,1
ucmscs,1
ultrasound,1
ultrasonography,1
ultraprotective ventilation,1
ultra-low-dose radiotherapy,1
ultra brief online mindfulness-based intervention,1
ulinastatin,1
uexplorer/mct,1
typical surgical covered mask,1
ultrasound of the lower limbs,1
type ii diabetes mellitus and covid-19 group (group ii),1
tympanic temperature,1
"two doses of placebo at the schedule of day 0, 28（middle-dose group）",1
"two doses of placebo at the schedule of day 0, 28（high-dose group）",1
"two doses of placebo at the schedule of day 0, 14 #middle-dose group#",1
"two doses of placebo at the schedule of day 0, 14 #high-dose group#",1
two doses of placebo at the routine vaccination schedule,1
ultrasound lung imaging as part of fast+ evaluation,1
ultrasound using the telerobotic melody system,1
urine samples,1
unfractionated heparin sc,1
urine collection,1
"urinary ngal, timp-2, igfbp7, il-6, viral load and metabolomic",1
unsupervised physical activities,1
unikinon (chloroquine phosphate) 200mg tablets,1
uniform random message delivery,1
unified protocol for covid-19 parenting stress (up-covid),1
uni911 inhalation,1
unfractionated heparin nebulized,1
umbilical cord derived mesenchymal stem cells,1
unfractionated heparin iv,1
unavailable covid test result - hypothetical scenario,1
umifenovir,1
umbilical cord wharton's jelly-derived human,1
umbilical cord mesenchymal stem cells + heparin along with best supportive care.,1
umbilical cord mesenchymal stem cells,1
umbilical cord lining stem cells (ulsc),1
two doses of placebo at the emergency vaccination schedule,1
"two doses of pilot scale inactivated sars-cov-2 vaccine at the schedule of day 0,14 in elderly",1
"two doses of pilot scale inactivated sars-cov-2 vaccine at the schedule of day 0,14",1
tricor® 145mg tablets,1
tuberculin test,1
tsu,1
trust in science message,1
trivalent split influenza vaccine,1
trimodulin,1
trimetazidine,1
trier social stress test,1
triazavirin (riamilovir),1
"two doses of middle-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 28",1
trial-based cognitive therapy,1
treatment with dexmedetomidine,1
"treatment group: will receive a combination of nitazoxanide, ribavirin and ivermectin for a duration of seven days :",1
treatment group,1
treatment for covid-19,1
treatment as usual vitamin d,1
treatment as usual (tau),1
turkish physicians,1
two covid-19 vaccine candidate (tmv-083) administrations - high dose,1
two covid-19 vaccine candidate (tmv-083) administrations - low dose,1
two dose chadox1 ncov-19/covishield 0.25ml & 0.5ml,1
"two doses of middle-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14",1
two doses of medium dosage inactivated sars-cov-2 vaccine at the routine vaccination schedule,1
two doses of medium dosage inactivated sars-cov-2 vaccine at the emergency vaccination schedule,1
"two doses of inactivated sars-cov-2 vaccine at the schedule of day 0,28 and one dose quadrivalent influenza vaccine on day 14.",1
"two doses of inactivated sars-cov-2 vaccine at the schedule of day 0,28 and one dose quadrivalent influenza vaccine on day 0 or day 28.",1
"two doses of high-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 28",1
"two doses of high-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14",1
"two doses of high dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1
two doses of high dosage inactivated sars-cov-2 vaccine at the routine vaccination schedule,1
two doses of high dosage inactivated sars-cov-2 vaccine at the emergency vaccination schedule,1
"two doses of commercial scale inactivated sars-cov-2 vaccine at the schedule of day 0,14",1
two doses of bnt162b2 vaccine,1
two dose menacwy vaccine min. 4 weeks apart,1
two dose menacwy vaccine,1
two dose chadox1 ncov-19/covishield 0.5ml,1
urine pregnancy test for women of childbearing potential,1
usb002,1
video dance classes,1
valsartan (diovan),1
vc,1
vbi-2902a,1
vb-201 + standard of care,1
vaxzevria,1
vascular surgery,1
vascular occlusion test,1
vas scale,1
valproate,1
vehicle + heparin along with best supportive care,1
validation of the poct antigen and antibody tests,1
validation of the ngs method,1
validation of the lamp assays,1
vaginal fluid covid-19 pcr test,1
vadadustat,1
vaccine therapy,1
vaccine inoculation against sars-cov-2,1
vcpm,1
venepuncture,1
use of continuous positive airway pressure,1
vib7734,1
video chat +personalized feedback,1
video chat + basic feedback,1
video call,1
video based exercise,1
video based aerobic exercise,1
video about safety and effectiveness of adult seasonal flu vaccination,1
vibrolung,1
vesta respirator,1
venipuncture in peripheral vein,1
verapamil,1
ventilatory support with oxygen therapy,1
ventaprost (inhaled epoprostenol delivered via a dedicated delivery system),1
venous draw & testing,1
venous blood was collected for biochemistry testing.,1
venous blood was collected for biochemistry testing,1
venous blood collection,1
vaccine coverage assessment,1
vaccine bcg,1
vaccine anti-covid19,1
usual antibiotic treatment,1
usual monitoring,1
usual emergency department practice with physician-directed diagnostic testing,1
"usual care, infection control briefing",1
usual care treatment,1
usual care positioning with no instructions,1
usual care only,1
usual care control,1
users,1
vaccine,1
use of virus (covid-19) genome sequence report to inform infection prevention control procedures,1
"use of the pinpointiq solution (physiq, inc.)",1
use of social media during covid-19,1
use of non-invasive ventilation,1
use of mobile application,1
use of high flow nasal cannula alone,1
use of facetime with child and parents during induction,1
usual orientations,1
usual treatments in intensive care unit according to the current state of knowledge,1
uttr1147a,1
uttr1147a-matched placebo,1
vaccination with janssen vaccine followed with pfizer vaccine (heterologous boosting).,1
vaccination with janssen vaccine followed with moderna vaccine (heterologous boosting).,1
vaccination with janssen vaccine followed with janssen vaccine (homologous boosting).,1
vaccination once with janssen vaccine (only priming),1
vaccination against covid19,1
vaccination,1
vaccinated with polio vaccine (ipv),1
vaccin box,1
vacciantion status in health care workers,1
v591,1
v590,1
v/q system,1
v/q spect-ct,1
v-sars,1
uv light treatment,1
study b,1
study a,1
racial/ethnic frame,1
saliva sampling,1
samling of oropharynx and nasopharynx,1
samba ii (diagnostic for the real world),1
sam-lnp-s-tce,1
sam-lnp-s,1
saliva-based testing,1
saliva test kit,1
saliva specimen,1
saliva sample combined to an anterior nare self-swabbing (self-samples),1
sample collection/performance evaluation (a),1
saliva sample (self-sample),1
saliva based assay: crude rna extraction,1
saliva assay,1
saliva and nps test,1
saline-sodium citrate (ssc) buffer,1
saline with baby shampoo nasal irrigation,1
saline placebo (single),1
sample,1
sample collection/performance evaluation (b),1
saline oral/nasal rinse,1
sarcopenia diagnosis,1
sars-cov 2 rna pcr urine,1
sars-cov 2 rna pcr semen,1
sars cov-2 swabs,1
sarilumab sar153191,1
sarilumab prefilled syringe,1
sarilumab 400 mg/2.28 ml subcutaneous solution [kevzara],1
sarilumab 200 mg/1.14 ml subcutaneous solution [kevzara],1
sar443122,1
sample of blood and saliva,1
sampling salivary,1
sampling of tissue,1
sampling of sars-cov-2 rna from nasopharyngeal swab specimen or saliva collected via salivette cortisol,1
sampling by venipuncture (and eventually by nasopharyngeal swab),1
"sampling (edta blood, pharyngeal and nose swabs, bronchoalveolar lavage ,urine)",1
sampling,1
sampler skills,1
saline placebo (double),1
saline nasal irrigation,1
scd,1
rosuvastatin,1
rt pcr,1
rph-104 80 mg,1
routine standard of care,1
routine psychological support,1
routine dental restorative procedures,1
routine care (no sars-covsts),1
roth´s test,1
robotic therapy,1
rt-pcr and antibody testing,1
robotic assisted intervention,1
robotic assisted early mobilization,1
robot assisted percutaneous cardiovascular intervention,1
roactemra sc,1
roactemra iv,1
ro7496998,1
rnapc2,1
rt pcr sars-cov-2,1
rt-pcr covid-19,1
saline nasal and throat spray,1
"sab-185 (3,840 units/kg)",1
saline control,1
saline containing 1% human serum albumin（solution without uc-mscs）,1
saline and saline,1
saline and listerine,1
saisei maf capsules,1
saint george respiratory questionnaire,1
sacubitril / valsartan oral tablet [entresto],1
"sab-185 (10,240 units/kg)",1
rt-pcr for sars-cov-2,1
"s-binding igg, rbd-binding igg and n-binding igg immunoassays and sars-cov-2 serum neutralization assay, quantitative serum immunoglobulin tests",1
s-1226,1
ruxolitinib plus simvastatin,1
ruxolitinib administration,1
ruxolitinib 5 mg,1
rt-qpcr test,1
rt-pcr sars-cov2,1
sars-cov-2 ab,1
sars-cov-2 adjuvanted recombinant protein vaccine (bivalent),1
sars-cov-2 adjuvanted recombinant protein vaccine (monovalent),1
"sars-cov-2 vaccine (vero cells), inactivated",1
sars-cov-2 viral composition,1
"sars-cov-2 vaccine(vero cell), inactivated",1
sars-cov-2 vaccine formulation 2 without adjuvant,1
sars-cov-2 vaccine formulation 2 with adjuvant 2,1
sars-cov-2 vaccine formulation 2 with adjuvant 1,1
sars-cov-2 vaccine formulation 1 with adjuvant 2,1
sars-cov-2 vaccine formulation 1 with adjuvant 1,1
"sars-cov-2 vaccine (vero cell), inactivated",1
sars-cov-2 vlp vaccine,1
sars-cov-2 vaccine (inactivated),1
sars-cov-2 vaccination,1
sars-cov-2 testing on the eppendorf thermal cycler pcr system using self-collected saliva as the specimen,1
sars-cov-2 testing,1
sars-cov-2 specific t cells,1
sars-cov-2 specific igm and igg detection,1
sars-cov-2 serological assessment (igg),1
sars-cov-2 virus vaccines,1
sars-cov-2-test,1
sars-cov-2 and/or mis-c exposure,1
savicell's immunobiopsy™,1
scb-2019 with as03 adjuvant,1
scb-2019,1
scarcity message,1
scarcity,1
scanning chest x-rays and performing ai algorithms on images,1
sc-ad6-1,1
sbi-101,1
satisfaction evaluation,1
sars-cov-2/influenza/rsv rt-pcr,1
sarscov2 convalescent plasma,1
sars-cov2-ctls,1
sars-cov2 serum antibody testing,1
sars-cov2 serology,1
sars-cov2 nasal swab,1
sars-cov2 autoantibody detection,1
sars-cov2 antibody measurement,1
sars-cov-2 screening by molecular biology,1
sars-cov-2 s1/s2 igg,1
sars-cov-2 rt-pcr assay for detection of covid-19 infection,1
sars-cov-2 ig g levels,1
sars-cov-2 mrna vaccine formulation 3,1
sars-cov-2 mrna vaccine formulation 2,1
sars-cov-2 mrna vaccine formulation 1,1
sars-cov-2 mrna vaccine (cvncov),1
sars-cov-2 infection,1
sars-cov-2 igg antibody testing kit,1
sars-cov-2 igg,1
sars-cov-2 convalescent plasma treatment,1
sars-cov-2 rs/matrix-m1 adjuvant (initial vaccination period),1
sars-cov-2 antigen-specific cytotoxic t-lymphocytes,1
sars-cov-2 antigen rapid test,1
sars-cov-2 antibody testing,1
sars-cov-2 antibody test,1
sars-cov-2 antibody immunoassays,1
sars-cov-2 antibody based ivig therapy,1
sars-cov-2 antibody analysis,1
sars-cov-2 neutralizing antibody titer,1
sars-cov-2 non-immune plasma,1
sars-cov-2 pcr and serology tests,1
sars-cov-2 plasma,1
sars-cov-2 rs/matrix-m1 adjuvant (crossover vaccination period),1
sars-cov-2 rs/matrix-m1 adjuvant,1
"sars-cov-2 rs/matrix-m adjuvant, days 0 and 21 - phase 2",1
"sars-cov-2 rs/matrix-m adjuvant, day 0 - phase 2",1
"sars-cov-2 rs/matrix-m adjuvant, day 0 - phase 1",1
sars-cov-2 rs/matrix-m adjuvant - phase 1,1
sars-cov-2 rs/matrix-m adjuvant - day 189 - phase 2,1
sars-cov-2 rs/matrix m1-adjuvant,1
sars-cov-2 rs - phase 1,1
"sars-cov-2 research in nasopharyngeal swab, sperm and serologics",1
sars-cov-2 recombinant protein vaccine formulation 3,1
sars-cov-2 recombinant protein vaccine formulation 2,1
sars-cov-2 recombinant protein vaccine formulation 1,1
"sars-cov-2 rapid diagnostic test (covid-presto® igm/igg, aaz, boulogne-billancourt, france)",1
sars-cov-2 questionnaire survey,1
rna vaccine,1
rivaroxaban 2.5 mg,1
rivaroxaban 15mg tab,1
recombinant human interferon alpha-1b,1
recombinant novel coronavirus vaccine (adenovirus type 5 vector) -placebo,1
recombinant new coronavirus vaccine (cho cell) group,1
recombinant ndv vectored vaccine for sars-cov-2,1
recombinant interferon alfa-2b,1
recombinant human plasma gelsolin (rhu-pgsn),1
recombinant human interferon α2b spray,1
recombinant human interferon α1β,1
recombinant human anti-sars-cov-2 monoclonal antibody(25mg/kg;50mg/kg;100mg/kg),1
recombinant novel coronavirus vaccine (adenovirus type 5 vector) 0.5ml,1
recombinant human annexin a5,1
recombinant human angiotensin-converting enzyme 2 (rhace2),1
recombinant bacterial ace2 receptors -like enzyme of b38-cap (rbace2) plus aerosolized 13 cis retinoic acid,1
recombinant bacterial ace2 receptors -like enzyme of b38-cap (rbace2),1
recombinant ad5 vectored covid-19 vaccine,1
recharge,1
recently vaccination,1
recombinant novel coronavirus vaccine (adenovirus type 5 vector) 0.3ml,1
recombinant novel coronavirus vaccine (adenovirus type 5 vector) for inhalation,1
rehabilitation by concentric exercises,1
referral and digital brochure,1
regular care,1
regn10933 + regn10987,1
registery data collection,1
regeneron casirivimab + imdevimab,1
regadenoson,1
reframing,1
referral card,1
reference: favipiravir 200 mg (avigan),1
recombinant sars-cov-2 ad5 vectored vaccine,1
rectal swab,1
recovered covid 19 patients plasma,1
recordings of cough sounds from adults,1
recording of respiratory monitoring,1
recording of hemodynamic monitoring,1
recombinase aided amplification (raa) assay,1
recombinant two-component covid-19 vaccine (cho cell),1
realtime pcr,1
real-time cgm,1
reading a book,1
random donor plasma,1
rapid antigen test for sars cov2,1
rapid antigen test (panbio ag test),1
rapid antigen test,1
rapid antibody test,1
rapamycin,1
rapa-501-allo off-the-shelf therapy of covid-19,1
randomized booster,1
ramipril 2.5 mg oral capsule,1
rdv placebo,1
ramelteon 8mg,1
"raman analysis of saliva, characterization of the raman database and building of the classification model",1
radx chcs testing intervention strategy,1
radius ppg tetherless pulse oximetry (masimo),1
radiotherapy,1
radiological detection,1
radiofrequency therapy,1
rapid antigen testing and offsite pcr testing,1
rapid antigen testing and onsite pcr testing,1
rapid antigen testing versus rt-pcr,1
rapid detection test,1
rdv,1
rd-x19,1
rbt-9 (90 mg),1
rbd-based protein subunit vaccine (zf2001) against covid-19,1
rba-2,1
razuprotafib subcutaneous solution,1
rayaldee 30mcg extended-release (er) capsule,1
rarefaction,1
rapid-3,1
rapid serological test,1
rapid salivary test,1
rapid pathogen detection,1
rapid onsite covid-19 detection,1
rapid nasopharyngeal antigen test for sars-cov-2,1
rapid molecular test,1
regular inpatient medical care,1
rehabilitation by eccentric exercises,1
ritonavir/lopinavir,1
"respiratory symptoms, symptoms of anxiety and depression, and post-traumatic stress screening",1
retrospective data and biological samples,1
retrospective case-control analysis,1
resveratrol placebo,1
restore: recovering from extreme stressors through online resources and e-health,1
resting 12 lead ecg,1
respiratory training,1
respiratory tele-rehabilitation program (trr).,1
respiratory swabs,1
reverse transcription polymerase chain reaction,1
respiratory supports,1
respiratory rehabilitation program (rr).,1
respiratory rehabilitation,1
respiratory physiotherapy,1
respiratory muscles ultrasound,1
respiratory monitoring,1
respiratory mechanics measurement,1
retrospective metagenomics on clinical samples collected during hospitalization,1
reverse-transcription polymerase chain reaction (rt-pcr),1
rehabilitation exercise protocol,1
rhtpo,1
ritonavir+oseltamivir,1
ritonavir,1
risankizumab,1
rintatolimod,1
ringer solution,1
ribavirin capsules,1
ria-device (remote investigation and assessment),1
mf59 adjuvanted sars-cov-2 sclamp vaccine 5mcg,1
review of medical file,1
rhdnase i,1
rhace2 apn01,1
reward re-training,1
revoxa oxygen rebrearther,1
revised home-cov score,1
reviewed clinical records and laboratory results,1
review of medical patient file,1
respiratory mechanics,1
respiratory infections,1
respiratory functions,1
remdesivir (rdv),1
remote ischemic conditioning,1
remote controlled exercise,1
remote consultation,1
remote cognitive behavioral therapy for insomnia,1
remote automated monitoring system,1
remimazolam,1
remdesivir-hu,1
remain covid free ssi,1
respiratory function rehabilitation training,1
relationship scales questionnaire (rsq),1
relation between frailty and clinical outcomes in elderly patients with covid-19.,1
rejuveinix (rjx) active comparator,1
reinforcement learning message delivery,1
rehabilitation-focused program,1
rehabilitation protocol through a digital platform,1
rehabilitation programme,1
remote monitoring of covid-19,1
remote problem management plus,1
remote pulmonary rehabilitation,1
remote service delivery model,1
respiratory exercise training,1
respiratory and psychological rehabilitation,1
resp301,1
resp-aer-meter,1
resp,1
resistance training,1
resilience program,1
research specific blood sample,1
rescure™,1
"reporting of anosmia, ageusia and other clinical symptoms",1
repeat sars-cov-2 igg antibodies at 45-65 days,1
renin-angiotensin system inhibitors,1
removal of dead space filter,1
"remotely monitored, mhealth (remm) supported high intensity interval training (hiit)",1
"remote sms (short message service, also known as ""text message"") delivery",1
scb-2019 with cpg 1018 adjuvant plus alum adjuvant,1
sch intervention,1
student-senior isolation prevention partnership (ssipp),1
spironolactone 100mg,1
stabilized hypochlorous acid,1
st266,1
st. george's respiratory questionnaire (sgrq),1
sse educational intervention,1
sras-cov-2 vaccination immunological response,1
sputum analysis,1
sputnik v,1
spironolactone + dexamethasone,1
staff will wear and evaluate bubble-papr (non-ce marked papr),1
"spirometry, thoracic ct, cpet, 6 minute walking test, sf-36 questionnaire",1
spin-chat program,1
spike protein (s) or the nucleocapsid (n) of sars-cov-2,1
sphenopalatine ganglion block with placebo (isotone nacl),1
sphenopalatine ganglion block with local anesthetic,1
sperm test,1
sperm collection,1
staff wellbeing centres,1
stakeholder of tip-oa program,1
speed of processing training,1
standard covid-19 therapies,1
standard message,1
standard medical care,1
standard mask,1
standard interface,1
standard guidelines,1
standard enteral nutrition,1
standard donor plasma,1
standard concomitant therapy,1
standar medical treatmen,1
standard charity resources,1
standard care plus monitoring,1
standard care delivered in the isolation hospitals.,1
standard administration of oxygen flow,1
"standard 12-lead ecg, nt-probnp, echocardiography",1
standard (specific) therapy for covid-19,1
standar of care,1
speq (specific psychotic experiences questionnaire) - paranoia and grandiosity subscales,1
specimens specific for the study,1
scheduled surgery,1
"sodium chloride, usp, for injection (0.9% nacl)",1
sofosbuvir ledipsavir,1
sofosbuvir and ledipasvir,1
sofosbuvir 400 mg/ daclatasvir 60mg,1
sofosbuvir 400 mg plus daclatasvir 200mg,1
sodium pyruvate nasal spray,1
sodium pyruvate,1
sodium nitrite,1
"sodium chloride, 0.9%",1
software messaging,1
sodium chloride 9mg/ml,1
sodium chloride 0.9%,1
sodium chloride,1
sodium bicarbonate 150meq/l/d5w inj,1
socialization,1
social proof,1
social network strategy + covid-19 messaging,1
sofosbuvir plus ledipasvir,1
sofusbuvir + daclastavir 60 mg,1
specimen collection,1
spartan covid-19 platform,1
specific exercise rehabilitation treatment,1
specific antibody and cellular immune response after anti-sars-cov-2 vaccine administration,1
specific anti-sars-cov-2 antibodies,1
spartan cube point-of care covid-19 test,1
spartan covid-19 v2 system,1
spartan covid-19 test,1
spartan covid-19 system,1
space parenting program,1
soluble urokinase plasminogen activator receptor,1
soton hyperinflammation score,1
soterix tavns model 0125-lte stimulator - sham-active group,1
soterix tavns model 0125-lte stimulator - active-active group,1
sonoclot,1
"sonclot coagulation and platelet function analyzer scp1, sienco, usa",1
sona saliva c-19 rapid test,1
solution-focused support program,1
standard of care (intravenous access),1
standard of care (paracetamol),1
standard of care (soc) + ang-3777,1
standards of care,1
stem cells,1
stem cell product,1
stem cell educator-treated mononuclear cells apheresis,1
steam inhalations,1
stc-19 score,1
statins (cardiovascular agents),1
state-trait anxiety inventory scale,1
standardized lung ultrasound (lus) examination,1
sterile normal saline (0.9%),1
standardized crisis management and coping protocol plan toward coronavirus disease 2019 (covid-19),1
standardized brazilian green propolis extract,1
standardised questionnaires,1
standard-titer convalescent covid-19 plasma (ccp2),1
standard-of-care treatment,1
standard-of-care sars-cov-2 treatment,1
standard-of-care,1
stepped-care model,1
sterile normal saline for intravenous use,1
standard of care (soc) + placebo,1
storage of operating waste,1
structured telephone support (sts),1
striveweekly,1
stress first aid,1
stress and emotion management,1
stress and anxiety questionnaire,1
stp + standard plasma (sp),1
stp + covid-19 convalescent plasma (cp),1
stools,1
sterile water for injection,1
stool collection or fecal swab,1
stool collection,1
stool analysis,1
stimulation test with arginine infusion in order to verify the possible existence of damage to the beta cell function induced by covid-19 infection,1
stigma awareness video intervention,1
sti-5656,1
steroid taper (prednisone),1
standard western medicine treatment,1
standard ventilation strategy,1
standard treatment of covid-19,1
standard of care thromboprophylaxis,1
standard oxygen therapy,1
standard oxygen delivery system,1
standard operating procedures,1
standard of health care,1
standard of care_2,1
standard of care_1,1
standard of care.,1
standard of care therapy,1
standard treatment according to the clinical protocols,1
standard of care therapies,1
standard of care management,1
standard of care for sars-cov-2 infection,1
standard of care for covid-19 as per the hospital guidelines,1
standard of care (soc) plus placebo,1
standard of care (soc) for covid-19,1
standard of care (soc) and colchicine+rosuvastatin,1
standard physiotherapy program,1
standard plasma (ffp),1
standard procedure,1
standard prophylactic dose enoxaparin/ unfractionated heparin,1
standard therapy recommended by the ministry of health of the russian federation.,1
standard therapy recommended by the ministry of health of the russian federation and dalargin intramuscular injection combined with dalargin inhalation,1
standard therapy recommended by the ministry of health of the russian federation and dalargin intramuscular injection,1
standard therapy recommended by the ministry of health of the russian federation and dalargin inhalation,1
standard therapy protocol (stp),1
standard therapy for covid-19 patient,1
standard therapy for covid-19 according to the stablished hospital protocols.,1
standard therapeutic protocol,1
standard supportive care,1
standard screening strategy,1
standard response team,1
"standard q covid-19 ag - test, produced by sd biosensor inc.",1
standard public health measures,1
standard pt,1
standard protocol,1
social media & news consumption,1
social distancing advertisements,1
social and public health measures against covid-19,1
seraph®-100 microbind® affinity blood filter,1
serologic sars-cov-2 screening,1
serologic immunoassays to sars-cov-2 antibodies,1
serologic immune response evaluation,1
serologic assays for antibodies to sars-cov-2,1
serodiagnosis of igg and igm,1
serial seroconversion measurements in hospital employees during the covid-19 pandemic,1
"serelogy testing, rt pcr",1
sequencing,1
serologic testing,1
sequence of testing.,1
separic-covid19 cohort,1
sentinox--group b,1
sentinox--group a,1
senti v1.0 device,1
sensiumvitals wearable sensor,1
sensbiosys,1
serologic test,1
serological analyses to be lead on a pre-existing biobank,1
seroprevalence of sars-cov-2 infection in patients with hiv infection,1
serological testing for covid-19 infection,1
"serology testing, rt pcr",1
serology testing profiles description,1
serology test follow-up,1
serology sars-cov2,1
serology for covid-19,1
serological tests will be applied on patients blood sampling,1
serological tests for sars cov-2,1
serological test for the detection of igg anti-sars-cov-2,1
serological assay for sars-cov-2,1
serological test for covid-19.,1
serological test and phone interview,1
serological surveillance,1
serological screening for igg and igm antibodies against covid-19,1
serological screening,1
serological covid-19 vaccine immunogenicity,1
serological assay or igg for sars-cov-2,1
senior fitness test,1
senicapoc,1
sending thorax ct video images via smartphone applications,1
"selenium, zinc and copper, vitamin a, d, e plasma concentrations during patient hospitalization",1
self-benefit,1
self-assesment questionnaire,1
self-administered structured questionnaire,1
self-administered questionnaires,1
self-acupressure,1
self study,1
self measurement with pulse oximeter,1
selenium (as selenious acid),1
semi-structured telephone questionnaire,1
secukinumab 150 mg/ml subcutaneous solution [cosentyx],1
secret questionnaire,1
sd biosensor,1
scta01 placebo,1
screening testing strategy,1
screening test for covid ( rt pcr and ct chest),1
schirmer test i,1
self-breathe,1
self-care tools,1
"self-collected, home-based testing",1
self-compassion for chronic pain virtual group treatment program,1
semi-structured interviews-patients,1
semi-structured interviews-health system,1
semi-directed entretien,1
semen qualitative analysis,1
semen analysis,1
semaglutide,1
self-questionnary,1
self-prone position recommendation,1
self-management booklet (switch: stay well during covid-19),1
self-interest message,1
self-help therapy,1
self-help mindfulness/compassion exercises,1
self-help booklet,1
self-guided exercises,1
self-focused acts,1
serology to determine sars-cov-2 infection,1
serum chemistry analysis,1
social,1
sirolimus 1 mg/ml,1
six minutes walk test,1
six minute walk test (6mwt),1
sitagliptin,1
sit-to-stand test,1
sit to stand test,1
sirukumab,1
sirtuin1,1
sir1-365,1
six-month arv dispensing,1
sinopharm vaccine,1
sinopharm,1
singstrong: strong lungs through song,1
single-nucleotide polymorphisms (snp) within the tcra/d region,1
single passive leg movement,1
single high dose vitamin d,1
single fraction whole lung radiotherapy,1
six-minute walk test (6mwt),1
skin biopsy,1
"serum collection, adverse events collection",1
sndx-6352,1
soc therapy,1
soc plus placebo iv,1
soc plus 15mg/kg eb05 iv,1
soc + intravenous famotidine,1
soc + ifx-1,1
soap distributed but no activities of the hbcc project,1
sno,1
sms-based support,1
sledd with a l-mod,1
sms message support,1
smoliv,1
smell training,1
smell household items,1
smartphone-based voice and self-reported symptom collection,1
sm-ema,1
slef questionnaires fulfilment,1
simulation of repurposed drugs for covid-19,1
simulation intervention,1
simple cognitive task,1
severe acute respiratory syndrome coronavirus 2 detection,1
sg diagnostics covid-19 antigen rapid test kit,1
sfrms/splf cpap-telemonitoring diagnosis/therapeutic algorithm.,1
"sf12, eq-5d-5l and work status standardized quantitative assessments",1
sf-12,1
sevoflurane inhalant product,1
severity of lung involvement with covid-19.,1
severe covid-19 pneumonia with et,1
service of questionnaire,1
simple chest tomography,1
"serum zinc, vitamin d vitamin b12 levels .",1
serum tube collection,1
serum test,1
serum sars cov 2 igg screening in health care workers,1
serum protein level analysis,1
serum ngal and cystatin c,1
serum inflammatory biomarkers,1
sham,1
sham acupressure group,1
sham device treatment,1
sham inflation,1
simha kriya,1
sildenafil citrate tablets,1
sildenafil,1
shorter duration higher frequency pt,1
shock-dependent hydrocortisone,1
"shingrix (zoster vaccine recombinant, adjuvanted)",1
shg,1
shared decision making,1
shanshamani vati plus,1
shampoo and saline,1
shampoo and listerine,1
sham treatment,1
sham transcranial direct-current stimulation,1
sham irradiation,1
sham intervention,1
mfs,1
low dose whole lung radiotherapy for older patients with covid-19 pneumonitis,1
mf59 adjuvanted sars-cov-2 sclamp vaccine 45mcg,1
clinical decision support system based on non-invasive multimodal monitoring,1
"clinical, laboratory and imaging characteristics of pneumonia",1
"clinical, functional and radiological lung involvement evolution",1
clinical trial matching,1
clinical observation,1
clinical interview,1
clinical features and laboratory values,1
clinical diagnosis of covid-19 by a health care professional,1
clia of igg and igm against sars-cov-2,1
cliniporator,1
clbs119,1
clazakizumab 25 mg,1
clazakizumab 12.5 mg,1
clarithromycin 500mg,1
clarithromycin,1
ckd-314+soc,1
ckd-314 placebo+soc,1
clinician endorsement,1
cliniporator® and epsgun,1
cimetra-2,1
cnm-znag,1
cod liver oil,1
coca is an observational study based on retrospective data issued from patient medial file.,1
"coaching, cleaning, communication, collaboration",1
co-ultrapealut,1
co-trimoxazole,1
co-mestring (co-coping),1
cns magnetic resonance imaging (mri) imaging,1
cm4620-ie (injectable emulsion),1
clofazimine,1
clungene rapid test cassette,1
cloth face mask,1
closys ultra sensitive rinse mouthwash,1
closed-loop control of oxygen supplementation by o2matic,1
closed face shield with surgical face mask use,1
clorhexidine dental phb©,1
clopidogrel 75mg,1
ck0802,1
cimetra-1,1
"cognitive behavior therapy (cbt), specifically using the facing your fears (fyf) curriculum",1
chest mri,1
chiropractic care,1
chinese medicine treatment,1
chinese herbal medicine,1
chest x-ray,1
chest radiography,1
chest physiotherapy using a non-invasive oscillating device,1
chest physiotherapy post-covid19,1
chest cta,1
chiropractic care (one visit),1
chest ct scan + baseline spirometry,1
chest ct scan,1
chest ct,1
chest computed tomography (ct),1
chest computed tomography,1
chemotherapy,1
chelsea critical care physical assessment tool,1
chiropractic care (more than one visit),1
chitotriosidase activity,1
cig tilted,1
choices and judgements,1
cig axial,1
ciclesonide metered dose inhaler [alvesco],1
ciclesonide inhalation aerosol,1
chx0.12+cpc0.05 oral rinse (perioaidactive control),1
chulacov19 mrna vaccine,1
"cholecalciferol 50,000 iu",1
"cholecalciferol 200,000 iu",1
choice of assignment: opt-in,1
chlorhexidine gluconate (a) mouth rinse with the solution provided,1
choice of assignment: enhanced active choice,1
choice of assignment: active choice,1
chlorpromazine (cpz),1
chlorpromazine,1
chloroquine phosphate tablets,1
chlorine dioxide 3000 ppm,1
chlorine dioxide,1
cognitive and behavioral intervention.,1
cognitive behavioral brief-telepsychotherapy,1
chatbot on covid-19 vaccine hesitancy,1
comparative observational cohort study,1
complementary and alternative medicine,1
complement dosage,1
compassion focused intervention,1
compass,1
comparison of sample collection methods,1
comparison of antigen tests with rt-pcr as reference method,1
comparison group,1
comparable placebo of oral polio vaccine and placebo of drug,1
complete thrombophilic profile testing by multiplex pcr,1
comparable placebo of drug,1
comparable placebo,1
community-driven messages to promote covid-19 testing,1
"community-based, mobile van testing",1
community popular opinion leader (pol) based intervention,1
community organization led outreach,1
community mask,1
"complete blood picture, bone marrow aspiration cytology",1
completion of covid19 vaccine at least 4 weeks ago,1
community health worker support,1
concentrate beetroot juice,1
confirm sars-cov-2 infection,1
confinement and communication during the covid-19 pandemic,1
conestat alfa,1
concurrent treatment of ptsd and substance use disorders using prolonged exposure (cope),1
concentrated rehabilitation for patients with persistent symptoms post covid-19,1
concentrated oxygen,1
concentrated air,1
computer task questionnaires,1
completion of post telemedicine encounter survey,1
computed tomography (ct),1
comprehensive treatment,1
comprehensive assessment of respiratory muscle function.,1
complication,1
complex diagnostic panel,1
completion of survey after peak of pandemic,1
completion of pre-pandemic survey,1
community interest message,1
communication type,1
cognitive behavioural group therapy for perinatal anxiety,1
colchicine 1 mg oral tablet,1
colgate total zero,1
colgate total clean mint,1
colgate peroxyl® mouthwash,1
colgate peroxyl® -1.5% hydrogen peroxide,1
colgate periogard® mouthwash,1
colchicine plus symptomatic treatment (paracetamol),1
colchicine pill,1
colchicine 0.6 mg,1
collagen-polyvinylpyrrolidone,1
cohort 3 hdt 301 vaccine,1
cohort 2 hdt 301 vaccine,1
cohort 1 hdt 301 vaccine,1
cognitive training,1
cognitive tests,1
cognitive testing,1
cognitive performance test,1
colgate total® mouthwash,1
collection of blood samples in order to create a biocollection,1
communication,1
com-covid anonimous survey,1
comirnaty - biontech manufacturing gmbh,1
"comirnaty (covid-19, mrna vaccine)",1
comet assay,1
combined use of a respiratory broad panel multiplex pcr and procalcitonin,1
combined art/hydroxychloroquine,1
combination of oral polio vaccine and na-831,1
combination,1
colorectal resections,1
"collection of blood, salivary and nasopharyngeal samples.",1
colonoscopy,1
collection of tears and saliva.,1
collection of swabs,1
collection of samples,1
collection of odour samples,1
collection of mucosal lining fluid,1
collection of breath sample,1
check-list including lung ultrasound,1
chat-based support,1
bovine plasma-derived immunoglobulin concentrate,1
butterfly,1
c2rx,1
c19-ig 20%,1
c144-ls and c-135-ls,1
c135-ls + c144-ls,1
c-reactive protein,1
bva-100,1
butterfly iq,1
burnout,1
cad3-ebo-s,1
budesonide nasal,1
budesonide dry powder inhaler,1
budesonide,1
buddy assigned in community,1
buddy,1
btl-tml-covid,1
bronchoalveolar lavage (bal),1
c3+ holter monitor,1
cad3-marburg,1
bronchial fibroscopy,1
canakinumab injection 600mg,1
cap-1002 allogeneic cardiosphere-derived cells,1
cap-1002,1
canswab,1
canrenoate potassium,1
"cannabis, medical",1
"cannabidiol, pharmaceutically produced with < 5 ppm thc",1
candesartan,1
canakinumab injection 300mg,1
cad4covid+wbc and covid-19 rdt for sars-cov-2 infection,1
canakinumab 150 mg/ml [ilaris],1
cambridge validated viral detection method,1
cam-icu 7 score,1
calm meditation app,1
calcium channel blockers,1
cag length >=22,1
cag length <22,1
broncho-vaxom®,1
bromhexine oral tablet and/or hydroxychloroquine tablet,1
capillary blood glucose testing with masked cgm,1
breath biopsy sampling using the reciva breath sampler,1
bresci̇a-covi̇d respiratory severity scale,1
brensocatib,1
breathing exercises,1
"breathing exercise, intensive spirometry use, supported cough, progressive mobilisation and ambulation",1
breathing exercise with the phone application,1
breath test & cheek swab,1
breath sample,1
breath biopsy analysis,1
bridge therapy,1
breath biopsy,1
breast feeding adherence,1
brazilian green propolis extract (epp-af),1
brainstem responses assessment sedation score (brass),1
brain mri scan,1
brain mri assessment,1
brain mri,1
brexanolone,1
brief behavioral activation with mental imagery,1
bromhexine hydrochloride tablets,1
brii-196,1
bromhexine hydrochloride,1
bromhexine and spironolactone,1
bromhexine 8 mg,1
bromelain,1
broad-spectrum cbd oil,1
brilacidin,1
brii-198,1
brief skills for safer living,1
brief cognitive behavioral therapy,1
brief psychiatric rating scale,1
brief mindfulness based intervention,1
brief interpersonal telepsychotherapy,1
brief informational infographic,1
brief educational video,1
brief counseling,1
brief cope scale,1
capillary and salivary sampling,1
capillary collection & testing,1
chat-based instant messaging support,1
cerc-002,1
chadox1 ncov-19 (abs 260),1
cetirizine and famotidine,1
certified cloth face mask plus preventive information,1
cereset research,1
"cerebrospinal fluid sampling, meningeal and brain parenchyma biopsies",1
cerebrolysin,1
cerebral compliance and hemodynamics monitoring,1
centricyte 1000,1
chadox1 ncov-19 (qpcr),1
cenicriviroc (cvc),1
cellulose-containing placebo capsules,1
cellular response,1
cellular and antibody response to spike antigens of sars-cov-2 in both groups in peripheral blood samples,1
cell therapy protocol 2,1
cell therapy protocol 1,1
celecoxib famotidine,1
chadox1 ncov-19 (abs 260) + 2.2x10^10vp (qpcr) boost,1
chadox1 ncov-19 0.5ml (3.5-6.5x10^10vp) late vaccine (lv),1
ceftaroline,1
chadv68-s-tce,1
chart review,1
change in preference to surgery under covid-19 pandemic.,1
"change in knowledge, motivation, skills, resources",1
change in kidney function and proteinuria,1
chamindwell,1
chair-yoga program,1
chain-referral,1
chadv68-s,1
chadox1 ncov-19 0.5ml (3.5-6.5x10^10vp) late vaccine two (lvt),1
chadox1-s [recombinant],1
chadox1 ncov-19 two dose + paracetamol,1
chadox1 ncov-19 single dose + paracetamol,1
chadox1 ncov-19 half boost,1
chadox1 ncov-19 full boost,1
chadox1 ncov-19 0.5ml prime plus boost,1
chadox1 ncov-19 0.5ml boost,1
ceftriaxone,1
cefditoren pivoxil 400mg,1
capnography,1
cardiopulmonary fitness level,1
care as usual,1
cardiovascular magnetic resonance imaging,1
cardiovascular magnetic resonance (cmr) imaging,1
cardiovascular and respiratory systems monitoring,1
cardiorespiratory exercise,1
cardiopulmonary stress test (cpet),1
cardiopulmonary resuscitation,1
cardiopulmonary exercise (online-based),1
care modalities. quantitative and qualitative approaches to analysis,1
cardiopulmonary exercise (centre-based),1
cardiac mri,1
cardiac magnetic resonance imaging (cmr),1
cardiac magnetic resonance imaging,1
cardiac ct,1
captopril 25mg,1
caption ai,1
care modalities,1
caring contacts,1
cd24fc,1
cash transfer,1
ccp,1
cbdra60 supplement,1
cbd isolate,1
cbd,1
cbc-diff monocyte volume width distribution,1
castem,1
casirivimab,1
case fatality rate,1
caring contacts plus introductory phone call (cc+),1
"cartography of air contamination, environment contamination and biological fluid by sars-cov2 during visceral surgery in covid19 patients.",1
carragelose,1
carrageenan nasal and throat spray,1
carotid-femoral pulse-wave velocity,1
carotid artery ultrasound measure,1
carotid artery reactivity testing,1
caring contacts without an introductory phone call (cc),1
congenital malformation,1
conjunctival rt pcr,1
conjunctival swab and nasopharyngeal swab,1
cries 13 questionnaire,1
cross-sectional study examining the impact of information sources to obtain information about covid-19 on depression and anxiety symptoms,1
cross-sectional observational study,1
cross sectional study using scientifically validated psychometric scales,1
cross sectional e-survey on surgeons exposed to any educational intervention,1
critical dialogue,1
crisis management coaching,1
crisis intervention therapy,1
cri management,1
cross-sectional survey,1
cretan iama,1
crest pro-health multi-protection mouthwash,1
credible messenger,1
cpi-006 2 mg/kg + soc,1
cpi-006 1 mg/kg + soc,1
cpi-006,1
cpg 1018/alum-adjuvanted scb-2019 vaccine,1
cross-sectional study investigating the association of npis with mental health,1
crp-apheresis,1
cpc,1
ct-p59/placebo,1
curosurf® (poractant alfa),1
curently used therapy for covid-19 non-critical patients,1
culturally adapted cognitive behavioral intervention (ca-cbi),1
cuff application with inflation,1
ctus examination,1
ct-v,1
ct-scan with minimal invasive autopsy,1
ct-imaging,1
cryo lung biopsies,1
ct score,1
ct of the chest,1
cst-5: placebo,1
cst-2: placebo,1
cst-2: eidd-2801,1
csl760,1
csl324,1
cpc+zn,1
cpap treatment,1
current clinical practices of participating physicians,1
covid-19 vaccine education campaign,1
covid-globulin,1
covid-evax,1
covid-antibody test,1
covid-19-impact on quality of life questionnaire,1
covid-19 vaccine moderna dispersion for injection - moderna biotech,1
covid-19 vaccine hesitancy scale in rheumatic diseases,1
covid-19 vaccine hesitancy associated factors,1
covid-19 vaccine astrazeneca suspension for injection,1
covid-surgres questionaire,1
covid-19 vaccination,1
covid-19 treatments,1
covid-19 treatment,1
covid-19 testing,1
"covid-19 test, polymerase chain reaction for sars-cov-2",1
covid-19 symptom monitoring system,1
covid-19 swap test pcr,1
covid-higiv,1
covid-viro® test,1
cpap,1
covigenix vax-001 placebo,1
covx,1
covvr,1
covsurf drug delivery system,1
covivac,1
coviv+iiv4; coviv+ppv23,1
coviv only (1st and 2nd dose),1
covishield,1
covigenix vax-001,1
covid19 convalescent plasma infusion,1
covigen 4.0 mg im or placebo im,1
covigen 2.0 mg im or placebo im,1
covigen 0.8 mg id or placebo id,1
covidseq test,1
covidfree@home,1
covid19 rt-pcr,1
covid19 immunization testing,1
current care per ucla treating physicians,1
current health,1
connect2test intervention,1
data collection from lumbar puncture,1
db-001,1
"data research, database analysis",1
data registry,1
data monitoring for 48h within the first 24 hours of admission for covid-19,1
data collection: clinical care assessments,1
data collection up to 1 year,1
data collection from medical files,1
data collection from blood draw,1
decidual stromal cells (dsc),1
data collection and rhinopharyngeal swab,1
data collection (,1
data collecting,1
dass-21 instrument (depression and anxiety),1
dass questionnaire,1
dasatinib anhydrous,1
das181 ol,1
"ddrops® products, 50,000 iu, oral",1
decision science-based design,1
darunavir/cobicistat,1
degarelix,1
"depression, anxiety and stress scale",1
depression,1
dental pulp mesenchymal stem cells,1
demographic and clinical data obtained from hospital's electronic medical record.,1
deltarex-g,1
delns1-ncov-rbd laiv,1
delayed vepmp intervention,1
defibrotide injection,1
decision tool for clinicians,1
defibrotide 25 mg/kg 24 hours continuous infusion for 15 days,1
deep venous disease diagnostic,1
deep breathing training,1
deep breathing exercise with triflo,1
dect,1
decitabine,1
decisions of limitations and stop processing,1
das181 covid-19,1
darunavir and cobicistat,1
current ipac-uhn ppe,1
cyp phenotyping,1
cytosorb,1
cytokines measurement,1
cytokines dosage,1
cytokine measurements,1
cytokine hemadsorption,1
cytokine adsorption,1
cyp-001,1
cynk-001,1
cytosorb-therapy,1
cyclosporin a,1
cycle threshold,1
cvncov 6 μg,1
cvncov 12μg,1
cvncov 12 μg,1
customized questionnaire,1
custom vr,1
cytosorb 300 ml device,1
cytotoxic t lymphocytes,1
dapsone 100 mg,1
daily syndromic surveillance,1
dapansutrile capsules,1
dapagliflozin 10 mg,1
dapagliflozin,1
danoprevir+ritonavir,1
dalteparin,1
dalcetrapib,1
daily vitamin d3,1
daily room disinfection,1
"d-beta-hydroxybutyrate-(r)-1,3 butanediol monoester",1
daily placebo,1
daily monitoring,1
daily coping toolkit,1
daclatasvir 60 mg,1
daad compound,1
"d-dimer,cbc.esr,crp,",1
d-dimer test,1
covid-19 swab pcr test,1
covid-19 swab,1
covid-19 standard care,1
conventional management of patients,1
conventional vaccine,1
conventional therapy first,1
conventional physical therapy,1
conventional oxygen,1
conventional n95 respirator,1
"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation, and lopinavir/ritonavir) and traditional chinese medicines (tcms) granules",1
"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation, and lopinavir/ritonavir)",1
conventional (low flow) oxygen delivery via nasal cannula,1
copan swabbing and blood sample collection,1
conventional,1
convenient scheduling link,1
convalesscent plasma,1
convalescent serum,1
convalescent sars covid-19 plasma,1
convalescent plasma with antibody against sars-cov-2.,1
convalescent plasma treatment,1
convp,1
coping strategies video,1
convalescent plasma infusion,1
coronavirus disease 2019,1
corticosteroids and derivatives,1
corticosteroid with or without colchicine,1
corticosteroid nasal irrigation,1
corticosteroid injection,1
corticosteroid alone,1
corsodyl® alcohol free -0.2 % chlorhexidine digluconate,1
coronovac,1
"coronavirus anxiety scale , covid-19 phobia scale",1
cor-101,1
coronavac vaccine,1
coronacidetm covid-19 igm/igg rapid test and premier biotech covid-19 igm/igg rapid test,1
coronacheck device,1
coromec registry with ecl-19,1
corn oil (placebo),1
core warming,1
cordio app,1
convalescent plasma of patients with covid-19,1
convalescent plasma from recovered covid 19 donor,1
covid-19 specific t cell derived exosomes (cstc-exo),1
continuous glucose monitor (cgm),1
contrast-enhanced cmr,1
continuous vital sign monitoring - isansys patient status engine,1
continuous renal replacement therapy,1
continuous positive airway pressure (cpap) treatment,1
continuous positive airway pressure (cpap) therapy using oxyjet,1
continuous positive airway pressure,1
"continuous glucose monitoring (cgm, dexcom g6)",1
continuous exercise training,1
control (albumin 5%),1
continuous blind glucose measurement device (free style pro),1
continuation of arb/acei,1
continuation of acei/arb,1
contain covid anxiety ssi,1
consultation,1
connor-davidson resilience scale 10 items (cd-risc 10),1
connected devices measurements,1
contrast-enhanced mri,1
control arm,1
convalescent plasma as therapy for covid-19 patients,1
control swab,1
convalescent plasma application to sars-cov-2 infected patients,1
convalescent plasma 2 units,1
convalescent plasma 1 unit,1
convalescent immune plasma,1
convalescent anti-sars-cov-2 plasma,1
controls,1
control test,1
control period,1
control blend,1
control patients,1
control message,1
control intervention,1
control group quality of life assessment,1
control group - waiting list,1
control group (standard hospital treatment),1
"control group (pharmacotherapy and/or psychotherapy, n=10)",1
corvax,1
cosh self-help smoking cessation booklet,1
cospherunate/azythromycine,1
covid-19 diagnostic and assessment tests,1
covid-19 group (group i),1
covid-19 group,1
covid-19 facility,1
covid-19 experience surveys,1
covid-19 e-package: psychological wellbeing for healthcare workers,1
covid-19 diagnostic test,1
covid-19 diagnostic pcr,1
covid-19 convalscent plasma,1
"covid-19 igg/igm rapid test cassette test (healgen scientific, houston, texas, usa)",1
covid-19 convalescent plasma treatment,1
covid-19 convalescent plasma (ccp) plus standard of care (soc),1
covid-19 convalescent plasma (ccp),1
covid-19 convalescent hyperimmune plasma,1
covid-19 breastfeeding support,1
covid-19 barrier box,1
"covid-19 antigen/antibody rapid testing, mobile device image capture and telemedicine support",1
"covid-19 igg / igm rapid test (whole blood, serum, plasma)",1
"covid-19 inactive vaccine, recombinant human adenovirus serotype number 26, mrna vaccine",1
cospherunate/phytomedicine/azythromycien,1
covid-19 positive,1
covid-19 serology igg,1
covid-19 sars-cov igg/igm antibody rapid test,1
covid-19 rt-pcr test,1
covid-19 related health warning leaflet,1
covid-19 presto test,1
covid-19 positive via testing,1
covid-19 positive pregnant women,1
covid-19 pneumonia,1
covid-19 infection status,1
covid-19 pcr swab,1
covid-19 pcr and serology testing,1
covid-19 pcr and serology,1
"covid-19 pcr , igm",1
covid-19 pcr,1
covid-19 nasal/pharyngeal swab,1
covid-19 monitoring using wearable sensors and smartphone technology,1
"covid-19 antigen and antibody tests, and influenza rapid test",1
covid-19 antibody testing (igg and igm),1
covid-19 antibody testing,1
covend24,1
covid 19 diagnostic test,1
covid 19 convalescent plasma,1
covicu,1
covi-vac,1
covi-guard,1
coverall personal protective equipment (ppe-c) suit,1
covepit (ose13e),1
covaxin,1
covid-19 antibody test,1
covax-19™,1
covax facts,1
covac-2,1
cov-scan rapid covid-19 antigen test,1
"couple hopes guided, internet-delivered, self-help intervention",1
cost-benefit frame,1
cost,1
covid 19 diagnostic test by pcr,1
covid 19 impact,1
covid 19 on pregnancy outcomes,1
covid 19 self-questionnaire,1
covid-19 antibody point of care test kit,1
covid-19 antibodies testing,1
covid-19 androgen sensitivity test (covast),1
covid-19 and intensive care,1
covid-19 + patients,1
covid wheld,1
covid watch,1
covid visitation restrictions,1
covid vaccines,1
covid rehabilitation program for the elderly (core),1
covid rehab formula granules,1
covid positive via testing,1
covid icu containment measures,1
covid detect,1
covid 19 serology,1
brac's business-as-usual,1
bovine lipid extract surfactant,1
mf59 adjuvanted sars-cov-2 sclamp vaccine 15mcg,1
alanine,1
alexa amazon,1
aldesleukin,1
alcohol-based hand sanitizer,1
alcohol mouthwash (listerine) (d) mouth rinse with the solution provided,1
alcohol based hand sanitizer,1
albuterol sulfate (nebulizer),1
albuterol sulfate (mdi),1
aks-452,1
all treatment about covid-2019,1
akl-t01,1
ak119,1
airway pressure release ventilation,1
airway management during sedation or general anesthesia,1
airwave oscillometry,1
airgo respiratory monitor,1
airflo2,1
alisporivir,1
allogeneic and expanded adipose tissue-derived mesenchymal stem cells,1
agent-797,1
"alpha-interferon alpha, abidol, ribavirin, buzhong yiqi plus and minus formula, huhuang detoxicity paste, baimu qingre jiedu paste, fumigation/inhalation of vitamin c",1
alveolar recruitment,1
alvelestat,1
alternate nostril breathing,1
alteplase,1
alpha1-proteinase inhibitor,1
"alpha-interferon, abidol, ribavirin, buzhong yiqi plus and minus formula, huhuang detoxicity paste, baimu qingre jiedu paste and high-dose vitamin c treatment",1
"alpha-interferon, abidol, ribavirin, buzhong yiqi plus and minus formula, huhuang detoxicity paste, baimu qingre jiedu paste and 5% glucose",1
alpha one antitrypsin inhalation,1
allogeneic and expanded adipose tissue-derived mesenchymal stromal cells,1
almitrine,1
allostim,1
allogenic pooled olfactory mucosa-derived mesenchymal stem cells,1
allogeneic wharton's jelly-mscs (wj-msc),1
allogeneic nk transfer,1
allogeneic mesenchymal stem cell,1
allogeneic human dental pulp stem cells (bsh btc & utooth btc),1
ai model,1
after-each-case room disinfection,1
amantadine,1
adenosine,1
administration of equine immunoglobulin anti sars-cov-2,1
adm03820,1
adjuvanted sars-cov-2 subunit vaccine (acov2),1
adjunctive therapies,1
adipose tissue,1
adimrsc-2f,1
adenovirus type-5 vectored covid-19 vaccine,1
additional ct acquisition,1
adsorbed sars-cov-2 (inactivated) vaccine,1
additional blood tubes,1
additional and minimal collection of products of the human body carried out during a sample for standard of care,1
adcovid,1
adcld-cov19,1
adapt-232 oral solution,1
adam sensor,1
adalimumab,1
admission to icu for covid-19,1
advance care planning video,1
after covid-19 pandemic,1
aerosolized 13 cis retinoic acid plus inhalation administration by nebulization captopril 25mg,1
african american sender in informational videos.,1
african american sender acknowledgement,1
aerosolized isotretinoin plus tamoxifen,1
aerosolized dnase,1
aerosolized all-trans retinoic acid plus oral tamoxifen,1
aerosolized all trans retinoic acid,1
aerosolized 13 cis retinoic acid plus inhalation inhaled testosterone,1
aerosolized 13 cis retinoic acid in combination with spike protein based vaccine,1
advance care planning video and conversation,1
aerosol-reducing mask,1
aerosol box (splashguard),1
aerolized hydroxychloroquine sulfate,1
aerobic training,1
aerobic exercises,1
aerobic exercise therapy,1
adx-629,1
ama acknowledgement drug pricing,1
amantadine hydrochloride,1
acupuncture and standard care,1
anti-sars-cov-2 igt seropositivity,1
antibiotics,1
antibiotic,1
anti-spike sars-cov-2 igg,1
anti-sars-cov2 serological controls and serum neutralization,1
anti-sars-cov-2 plasma,1
anti-sars-cov-2 immunoglobulin,1
anti-sars-cov-2 igy,1
anti-sars-cov-2 equine immunoglobulin fragments (inosars),1
antibody test (sars-cov2),1
anti-sars-cov-2 antibody testing,1
anti-sars-cov-2,1
anti-covid-19 human immunoglobulin,1
anti-covid test,1
anti-coronavirus antibodies (immunoglobulins)obtained with dfpp from convalescent patients,1
anti-coronavirus antibodies (immunoglobulins) obtained with dfpp form convalescent patients,1
anti-cd14,1
antibodies testing,1
antibody testing,1
anti sars-cov-2 equine hyperimmune serum,1
antioxidation therapy,1
anxiety and depression assessment,1
anxiety,1
antroquinonol,1
antiviral agents,1
antithrombotic therapy (anticoagulant and/or antiplatelet) before admission for covid19,1
antithrombin + best available treatment,1
antisars-cov-2 serum,1
antimicrobial stewardship prospective audit and feedback,1
antibody testing for sars-cov-2 igg,1
antihypertensive agents,1
antigen detection test,1
antidiabetic treatment,1
anticoagulation agents (edoxaban and/or high dose lmwh),1
anticoagulant therapy,1
antibody-rich plasma from covid-19 recovered patients,1
antibody titration,1
anti- sars-cov-2 plasma,1
anti sars-cov 2 convalescent plasma in severe covid-19 patients,1
amh sampling,1
an69-standard,1
anakinra plus osoc,1
anakinra and ruxolitinib (overcome stage 3),1
anakinra and ruxolitinib (advanced stage 3),1
anakinra alone (stages 2b/3),1
anakinra 149 mg/ml prefilled syringe [kineret],1
anakinra 100mg/0.67ml inj syringe,1
anakinra +/- ruxolitinib (stages 2b/3),1
an69-oxiris,1
analog scale,1
an auto-questionnaire comprising three psychometric scales,1
amy-101,1
amoxicillin/clavulanate,1
amoxicillin-clavulanate,1
amor 18 powder & inhalation,1
amlodipine,1
amiodarone,1
anakinra prefilled syringe,1
"analogs, prostaglandin e1",1
anti sars-cov 2 convalescent plasma in critical covid-19 patients,1
angiotensin receptor blocker,1
anti covid19 igg antibodies,1
anti covid 19 intravenous immunoglobulin (c-ivig),1
anonymous survey,1
anne one,1
anluohuaxian,1
angiotensin-converting enzyme inhibitors (ace-i) and angiotensin ii receptor blockers (arb),1
angiotensin receptor blockers,1
angiotensin ii receptor blockers,1
analysis of blood samples,1
angiotensin ii,1
angiography scanner,1
anger message,1
anesthesia management,1
anatolian propolis,1
"analysis of cytokine response, innate and adaptive immune response, complement activation, and serum neurofilaments as a marker of neurological damage.",1
analysis of cell-mediated and antibody-mediated immunity to sars-cov-2 virus,1
ad5-ncov,1
activity list,1
bovhyaluronidase azoxymer,1
20-valent pneumococcal conjugate vaccine (20vpnc),1
25-oh cholecalciferol,1
25 µg spfn_1b-06-pl + alfq (qs21 adjuvant),1
25 post non-icu patients,1
25 post icu-patients,1
24 hour holter ecg,1
2019-ncov pcr,1
2019-ncov igg/igm rapid test cassette,1
20% adoption rate,1
2: continuation of ras blocker therapy,1
20 mg prednisone for 14 days,1
2 post-mortem transcutaneous lung biopsies (1 anterior ; 1 posterior) using anatomical landmarks,1
2 doses of vaccine,1
1: usual practice,1
1: prone positioning,1
1: naproxen,1
1: ilt101,1
27% ethanol plus essential oils,1
2: no instruction regarding positioning,1
18f-αvβ6-bp,1
"35 ml blood, 5 tubes lithium heparinate at each time (cured patients)",1
40ml blood sample,1
40-steps-test,1
40% adoption rate,1
4-week intervention,1
38-questions questionnaire,1
38 questions questionnaire,1
"35 ml blood, 5 tubes lithium heparinate at each time (hospitalized patients )",1
30 µg cov2 sam (lnp),1
2: placebo comparator,1
"3-doses schedule 3 of covid-19 vaccine (vero cell), inactivated",1
"3-doses schedule 2 of covid-19 vaccine (vero cell), inactivated",1
"3-doses schedule 1 of covid-19 vaccine (vero cell), inactivated",1
3-dayivm 200 mcg/kg/day/14-day 75mgasa/day + standard of care (intervention 1),1
3 µg cov2 sam (lnp),1
2: usual practice + symbicort rapihaler,1
2: standard of care,1
1: discontinuation of ras blocker therapy,1
18f-fdg pet-ct,1
5 blood samples,1
0.075% cetylpyridinium chloride,1
0.5% povidone/iodine oral/nasal rinse,1
0.5% povidone iodine,1
0.12% chlorhexidine oral/nasal rinse,1
0.12% chlorhexidine gluconate mouth rinse,1
0.12% chlorhexidine gluconate,1
0.1% sodium hypochlorite,1
0.075% cetylpyridinium chloride (cpc),1
0.07% cetylpyridinium chloride (cpc) in mouthwash,1
0.6% pvp-i oral and nasal spray to asymptomatic to mild covid-19 patient having multiple comorbidity,1
"0, 28 day schedule",1
"0, 112 day schedule",1
0% adoption rate,1
- synthetic anti-malarial drugs,1
(standard of care) soc,1
"""vernonia amygdalina""",1
"""sham""-block with placebo (isotone nacl)",1
0.5% w/v povidone-iodide,1
0.6% pvp-i oral and nasal spray to healthy volunteer,1
150 ppm nitric oxide delivered through lungfit delivery system,1
1% hydrogen peroxide,1
13 cis retinoic acid doses orally in combination with spike protein based vaccine,1
10% povidone-iodine nasal decolonization swab plus 0.12% chg oral rinse,1
10 µg cov2 sam (lnp),1
1.5% w/v hydrogen peroxide,1
1.5% hydrogen peroxide (h2o2),1
1. characterize the immune response after infection with sars-cov-2,1
1% povidone iodine (pvp-i),1
1 µg cov2 sam (lnp),1
0.6% pvp-i oral and nasal spray to moderately ill covid-19 positive patient,1
1 minute sit to stand test,1
0.9%nacl,1
0.9% sodium-chloride,1
0.9% sodium chloride (normal saline),1
0.9% sodium chloride,1
0.9% normal saline,1
0.9% (w/v) saline,1
4plants/azythromycin,1
5 times sit to stand test,1
activity,1
abx464,1
accuchek inform ii platform,1
acceptance and commitment therapy (act) exercises,1
acalabrutinib treatment d,1
acalabrutinib treatment c,1
acalabrutinib treatment b,1
acalabrutinib treatment a,1
acacia senegal,1
abpm,1
"ace inhibitor, angiotensin receptor blocker",1
abncov2 vaccine,1
abivertinib,1
abidol hydrochloride combined with interferon atomization,1
abdominal ultrasound,1
abbv-47d11,1
abbv-2b04,1
abbc1 immunoessential,1
accuracy of cad4tb and afinion crp assay for pulmonary tb,1
ace inhibitors and calcium channel blockers,1
aat( alpha 1 antitrypsin),1
act-20-msc,1
active placebo,1
active pbmt/smf,1
active covid-19 disease,1
active control:healthy living,1
active comparator: self-care group,1
active comparator,1
actigraphy,1
act-20-cm,1
acei,1
act,1
"acp educator led, video assisted discussion",1
acp decisions video program,1
acknowledgement racial injustice ama,1
acetyl l-carnitine,1
aceis,1
acei/arb,1
aaz covid-19 rapid test,1
a vignette intervention,1
5-ala-phosphate + sfc (5-ala + sfc),1
60% adoption rate,1
[18f]fp-r01-mg-f2,1
[18f]feppa pet scan,1
[18f]f-arag (2'-deoxy-2'-fluoro-9-β-d-arabinofuranosylguanine),1
[11c]sl25.1188 pet scan,1
99mtc-pertechnetate,1
80% adoption rate,1
80 ppm nitric oxide delivered through lungfit delivery system,1
6-min-walk without mask,1
[89zr]df-iab22m2c pet/ct scan,1
6-min-walk surgical mask,1
6-min-walk fpp2,1
6 point likert scale,1
6 minutes walk test,1
50 µg spfn_1b-06-pl + alfq (qs21 adjuvant),1
5-week prevention program,1
5-ala-phosphate + sfc (5-ala+sfc),1
[68ga]ga-dota-(rgd)2 pet/ct,1
[timp-2]*[igfbp-7],1
a survey of 60 questions was created through the internet-based 'google forms surveys' site.,1
"a middle-dose recombinant covid-19 vaccine (cho cell) (18-59 years) at the schedule of day 0, 28, 56",1
a survey form was applied to individuals included in the study face-to-face.,1
a survey,1
a specifically designed self-administered questionnaire,1
a short video intervention,1
a questionnaire or scales,1
a questionnaire and scales.,1
"a middle-dose recombinant covid-19 vaccine (cho cell) (60-85 years) at the schedule of day 0, 28, 56",1
"a middle-dose placebo (60-85 years) at the schedule of day 0, 28, 56",1
a $10 survey incentive,1
"a middle-dose placebo (18-59 years) at the schedule of day 0, 28, 56",1
"a high-dose recombinant covid-19 vaccine (cho cell) (60-85 years) at the schedule of day 0, 28, 56",1
"a high-dose recombinant covid-19 vaccine (cho cell) (18-59 years) at the schedule of day 0, 28, 56",1
"a high-dose placebo (60-85 years) at the schedule of day 0, 28, 56",1
"a high-dose placebo (18-59 years) at the schedule of day 0, 28, 56",1
a 940-nm diode laser,1
a $20 survey incentive,1
anxiety reduction training,1
any drug used to treat covid-19,1
ap-23,1
beva+soc,1
bi 767551 inhaled,1
bi 767551 inhalation,1
bi 764198,1
bge-175,1
bgb-dxp593,1
bgb dxp593,1
bevacizumab,1
betadine© bucal 100 mg/ml,1
bidirectional oxygenation mouthpiece,1
betadine (c) mouth rinse with the solution provided,1
best supportive care (bsc),1
best standard of care + cardio,1
best message alone,1
best message + augmented message or implementation strategy,1
best available therapy,1
best available care,1
bicalutamide 150 mg,1
big five inventory (bfi) scale,1
berberine,1
biological,1
biological samples day of delivery,1
biological samples collection,1
biological sample and clinical data collection,1
biological sample,1
"biological collection with nasopharyngeal samples, saliva, blood, stool and urine",1
biological collection (patients co infected hiv sras-cov-2),1
biological assays in particular on the lipid metabolism,1
biocollection,1
bio 300 oral suspension,1
biochemistry blood test,1
biochemical analysis,1
biochemical analyses,1
biobehavioral tele-rehabilitation sessions,1
biobank,1
bioarginina®,1
bio101,1
bereavement virtual support group,1
bempegaldesleukin,1
"biological samples, questionnaires and interviews",1
baseline message,1
bbv152b - phase i,1
bbv152a - phase ii,1
bbv152a - phase i,1
bat2020,1
bat + calcifediol,1
bat,1
basic body awareness therapy,1
baseline disease modifying therapies (dmts),1
bbv152c - phase i,1
baseline blood sample,1
baseline and during hospitalization blood samples,1
base therapy,1
baricitinib oral tablet [olumiant],1
baricitinib or anakinra,1
baricitinib 4 mg oral tablet,1
baricitinib + dexamethasone,1
bbv152b - phase ii,1
bbv154 vaccine,1
bemiparin sodium,1
bedside lung ultrasound,1
bemcentinib,1
behaviour change technique intervention to improve quality of life,1
behavioral: ocat-sham,1
behavioral: ocat,1
behavioral economics,1
behavioral and cognitive assessment,1
behavioral activation ssi,1
beck depression inventory (bdi),1
bcg,1
beck depression inventory,1
beck anxiety inventory,1
bdb-001 injection,1
bd veritor plus system for rapid detection of sars cov-2,1
bcg-10 vaccine,1
bcg vaccine (freeze-dried),1
bcg group,1
biological samples specific to research,1
biological sampling,1
apabetalone,1
blood sampling (venesection),1
bloodwork,1
blood- and saliva tests,1
"blood tests sputum, nasal lavage and brushing",1
blood test for sars-cov2 serology,1
blood test for inflammatory markers,1
blood test for igg antibodies against sars-cov-2,1
blood sampling for biobank,1
blood sampling (4 per year),1
bm-mscs,1
blood samples for the study of the humoral response to sars-cov-2 variants and of the cellular response after vaccination against covid-19,1
blood samples collection,1
blood samples (collection of 5 ml of blood in a dry tube),1
blood sample for whole genome sequencing,1
blood sample for serology to measure past infection with sars-cov-2,1
blood sample for serological test,1
blood sample for seroepidemiological investigation,1
bm-allo.msc,1
bms-986253,1
blood sample and salivary sample,1
bnt162c2,1
botulinum neurotoxin,1
bone marrow mesenchymal stem cell derived extracellular vesicles infusion treatment,1
bone marrow harvest,1
bone conduction headphones,1
bolus vitamin d3,1
bolus placebo,1
body position change,1
bnt162b3,1
bno 1030,1
bnt162b2sa,1
bnt162b2.b.1.351,1
bnt162b2 vaccine,1
bnt162b2 mrna covid-19 vaccine,1
bnt162b2 30mcg,1
bnt162b2 20mcg,1
bnt162a1,1
blood sample collection,1
blood sample and data record,1
biological test,1
biological: spike protein based vaccine such as chadox1 ncov-19 vaccine,1
biosensors,1
biopsies of subcutaneous adipose tissue,1
biomedomics covid-19 igm-igg rapid test,1
biomarkers of inflammation,1
biomarkers in the long term impact of coronavirus infection in the cardiorrespiratory system,1
biomarkers expression,1
"biomarker (tropt, myoglobin, ck, ck-mb, ldh, d-dimer, crp, pct)",1
biological: oral polio vaccine,1
biozek covid-19 antigen rapid test,1
biological: mrna-1273,1
biological: covid-19 convalescent plasma,1
biological/vaccine: recombinant new coronavirus vaccine (cho cells) placebo group,1
biological/vaccine: recombinant new coronavirus vaccine (cho cells) high-dose group,1
biological/vaccine: recombinant new coronavirus vaccine (cho cell) low-dose group,1
biological/vaccine: bnt162b2 10mcg,1
biological/vaccine: angiotensin peptide (1-7) derived plasma,1
biovitals,1
biozek covid-19 antigen rapid test (saliva),1
blood sample analyses,1
blood count,1
blood plasma,1
blood group determination,1
blood for research purposes,1
blood for pharmacokinetic samples,1
blood for anti-drug antibody (ada),1
blood donation from convalescent donor,1
blood d-dimer assay,1
blood collection via fingerprick,1
bivalirudin injection,1
"blood collection at day 8, day 16, day 24, month 6 and month 12 after first symptoms from sars-cov-2 infection",1
blood and derivatives.,1
blood analysis,1
blink and masseter inhibitory reflex,1
blended gaming covid-19 training system (bgcts),1
bld-2660,1
black seed oil cap/tab,1
baricitinib (janus kinase inhibitor),1
bariatric procedures,1
bardoxolone methyl,1
ashmolean website,1
assessing the impact of covid-19,1
"assessing antibody responses, neutralizing capacity and memory b-cell function",1
assembled mask,1
aspirin 81 mg,1
aspirin 75mg,1
aspirin 100mg,1
asp,1
ascorbic acid and zinc gluconate,1
"assessment of coagulopathy, platelets activation and platelets-neutrophils interplay",1
asc09f+oseltamivir,1
asc09/ritonavir group,1
asbrip,1
artesunate-amodiaquine,1
artesunate,1
arterial blood gas test (abg),1
arterial blood gas (abg),1
assessment of cardiovascular diseases and cardiovascular risk factors,1
assessment of dietary changes in adults in the quarantine,1
artemisinin / artesunate,1
assisting to the event,1
asunercept 400mg,1
asunercept 25mg,1
asunercept 100mg,1
asunercept,1
astrostem-v,1
astrazeneca/oxford vaccine,1
association of diltiazem and niclosamide,1
assist,1
assessment of lung mechanics and heart-lung interactions,1
assigned strategies: opt-in,1
assigned strategies: enhanced active choice,1
assigned strategies: active choice,1
assessment of ventilator-associated pneumonia criteria,1
assessment of the sequelae after hospitalization for sars-cov-2,1
assessment of proinflammatory cytokine production and immunophenotypic analysis after stimulation with overlapping s-peptides in peripheral blood mononuclear cells (pbmc),1
assessment of postnatal depression using the the edinburgh questionnaire between 4 and 6 weeks after delivery,1
arterial blood gas,1
artemisinin,1
balanced amino acid,1
apremilast placebo,1
arbs and/or ace inhibitors,1
arbox,1
arbidol hydrochloride granules,1
arbidol 100 mg kapsul,1
apx-115,1
aprotinin,1
aprepitant injectable emulsion,1
apps,1
arct-021 dose 1,1
application of cdss to provide nutritional care in breast cancer patients from home,1
apple watch series 5,1
appendicectomy,1
apo-hydroxychloroquine,1
apl-9,1
apixaban 5mg,1
apilimod dimesylate capsule,1
arct-021,1
arct-021 dose 2,1
artemisia annua leaf,1
arfc mask,1
artemic,1
artemether-lumefantrine (al),1
artemesia annua,1
artecom® (pyronaridine-artesunate),1
art therapy,1
art,1
argatroban,1
ardsnet,1
arct-021 dose 3,1
ards and covid19 treatments,1
arct-021 two lower dose priming,1
arct-021 two higher dose priming,1
arct-021 single dose priming,1
arct-021 dose regimen 2,1
arct-021 dose regimen 1,1
arct-021 dose 4,1
asynchronies detection,1
asynchronous telerehabilitation programme,1
at-001,1
azd7442 (im),1
azithromycin (azithro),1
azinc,1
azd7442 600 mg im (male),1
azd7442 300 mg iv (male and female),1
azd7442 300 mg im(male),1
azd7442 1000 mg iv (male),1
azd7442 (iv),1
azd1656,1
azithromycin / ribaroxaban / paracetamol,1
ayurvedic kadha,1
axillary sweat sample,1
award plus covid-specific advice,1
award advice,1
awake prone position,1
avm0703,1
aviptadil placebo,1
azithromycin / ivermectin / ribaroxaban / paracetamol,1
azithromycin 250 mg,1
at-100,1
açaí palm berry extract - natural product,1
balance assessments,1
baf312,1
bactrl-spike,1
bacterial species isolated,1
bactek-r,1
bacmune (mv130),1
background questionnaire,1
azvudine placebo,1
azithromycin 250 mg oral capsule,1
azvudine,1
azoximer bromide,1
azithromycin with amoxicillin/clavulanate,1
azithromycin capsule,1
azithromycin and hydroxychloroquine,1
azithromycin 500mg oral tablet,1
azithromycin 500 milligram (mg) oral tablet,1
aviptadil by intravenous infusion + standard of care,1
aviptadil 67μg,1
aviptadil,1
atorvastatin 80mg,1
atyr1923 3 mg/kg,1
atyr1923 1 mg/kg,1
attention control,1
attendance by ambulance crew,1
atr-002,1
atovaquone/azithromycin,1
atorvastatin-ezetimibe,1
atorvastatin 40mg,1
avigan 200 mg ft,1
atorvastatin 20mg,1
atorvastatin 20 mg oral tablet,1
atorvastatin + l-arginine + folic acid + nicorandil + nebivolol,1
ati-450,1
atazanavir and dexamethasone,1
atazanavir,1
atafenovir 200 mg kapsul,1
audio-vestibular evaluation,1
audio-visual triage system (avt),1
auditory evoked potentials (aep),1
auricular neuromodulation,1
avicod 200 mg film tablet,1
av-001,1
auxora,1
autophagy inhibitor (gns651),1
automated oxygen administration - freeo2,1
autologous stem cell transplantation,1
autologous non-hematopoietic peripheral blood stem cells (nhpbsc),1
autologous hb-admsc's,1
autologous adipose-derived stem cells,1
autologous adipose msc's,1
autologous activated platelet-rich plasma,1
auto-questionnaires (patients co infected hiv sras-cov-2),1
auscul-x,1
auricular stimulation,1
auricular percutaneous neurostimulation,1
descartes 30,1
description of groups caracteristics,1
desferal 500 mg injection,1
injectable placebo,1
inspiratory + expiratory muscle training group,1
inopulse,1
ino (inhaled nitric oxide) delivered via the inopulse delivery system,1
innova lateral flow device,1
inm005,1
injection of secretome-mscs,1
injection and infusion of lv-smenp-dc vaccine and antigen-specific ctls,1
inhaled type i interferon,1
inspiratory muscle and exercise training,1
inhaled supplemental oxygen,1
inhaled sedation,1
inhaled nitric oxide gas,1
inhaled nitric oxide (ino),1
inhaled iloprost,1
inhaled hypertonic ibuprofen,1
inhaled hydroxychloroquine,1
inspiratory + expiratory muscle training placebo group,1
inspiratory muscle traiing,1
inhaled aviptadil,1
insulin regimen,1
interferon β-1b,1
interferon or glatiramer acetate,1
interferon alfa,1
intensive care unit admission ratio,1
intellivent asv,1
integrated clinical evaluation,1
insurance navigation,1
insulin film,1
inspiratory muscle trainer,1
insulin,1
instrumental activities of daily living shaping,1
instilled t3,1
inspiratory training device,1
inspiratory muscle training placebo group,1
inspiratory muscle training group,1
inspiratory muscle training,1
inhaled budesonide,1
inhalation of n-acetylcysteine,1
interferon-beta,1
inc424 / ruxolitinib,1
indirect calorimetry,1
independent control,1
incremental shuttle walk test,1
increasing willingness and uptake of covid-19 vaccination,1
increasing willingness and uptake of covid-19 testing and vaccination,1
incidence of bleeding complications in ards patients on veno-venous ecmo,1
incentive spirometer/respiratory exerciser,1
inb03,1
individualized-chinese herbal medicine,1
inactive sars-cov-2 vaccine (vero cell),1
inactivated sars-cov-2 vaccine (vero cell）,1
inactivated sars cov 2 vaccine (vero cell) wuhan/beijing/placebo,1
inactivated convalescent plasma,1
in01 vaccine,1
in-person postoperative visit,1
in-person monitoring,1
individualised ayurveda,1
indomethacin,1
"inhalation of 8,4% sodium bicarbonate",1
informational videos and social media campaigns encouraging cancer screening.,1
inhalation of 5% sodium chloride,1
inhalable hydroxychloroquine (hcq),1
infusion placebo,1
infusion iv of mesenchymal stem cells,1
infrared energy and dietary supplement,1
informed consent,1
informed,1
informational sheet,1
infectious disease and cardiology clinical consultations,1
information on covid-19,1
information assigned in community,1
inflammatory markers sampling,1
inflammatory cytokines and chemokines profiles of patients with dexmedetomidine administration,1
inflammation (iii),1
inflammation (ii),1
inflammation (i),1
interferon-alpha2b,1
interferon-ß-1a,1
in-hospital mortality rate,1
investigation of smell and taste disorders,1
"investigational vaccine against sars-cov-2 [mv-014-212] dosage 3, two doses, intranasal drops",1
"investigational vaccine against sars-cov-2 [mv-014-212] dosage 3, single dose, intranasal spray",1
"investigational vaccine against sars-cov-2 [mv-014-212] dosage 3, single dose, intranasal drops",1
"investigational vaccine against sars-cov-2 [mv-014-212] dosage 2, single dose, intranasal drops",1
"investigational vaccine against sars-cov-2 [mv-014-212] dosage 1, single dose, intranasal drops",1
investigational product - viracide,1
investigation of the prevalence of test positivity,1
invasive ventilation strategy,1
iota-carrageenan,1
invasive mechanical ventilation using the unisabana-herons ventilator during 24 hours,1
invasive mechanical ventilation,1
intubation box,1
intravenous sedation,1
intravenous saline injection (placebo),1
intravenous infusions of stem cells,1
intravenous immunoglobulin therapy,1
iota carrageenan nasal spray and ivermectin oral drops (used as buccal drops),1
ip-10 in cds protocol,1
intravenous immune globulin,1
isotretinoin (13 cis retinoic acid ) capsules,1
iv tocillizumab (tcz),1
iv dexamethasone,1
iv deployment of csvf in sterile normal saline iv solution,1
itolizumab iv infusion,1
it is a survey,1
isotretinoin(aerosolized 13 cis retinoic acid) +standard treatment,1
isotretinoin only product in oral dose form,1
isotonic saline 0.9%,1
ipss questionnaire,1
isotonic saline,1
isoquercetin (iqc-950an),1
isoprinosine,1
isoflurane inhalant product,1
isis 721744,1
isavuconazonium injection [cresemba],1
irl201104,1
intravenous immunoglobulin,1
intravenous drug,1
interferon-β 1a,1
intermediate dose thromboprophylaxis,1
internet-based self-help after 3 weeks,1
internet-based self-help,1
internet-based intervention,1
internet-based guided self-help based on cbt principles,1
internet-based cognitive behavioral therapy,1
internet cognitive behavioral therapy plus chamindwell,1
intermittent prone positioning instructions,1
intermediate dose enoxaparin/ unfractionated heparin,1
interpersonal psychotherapy,1
interleukin-6 gene-174c detection,1
interleukin-1 receptor antagonist,1
interleukin assessment in semen,1
interleukin 6 (il6) antagonist and corticosteroids,1
interleukin 6 (il6) antagonist,1
interleuken 6 level measurment,1
interferon-β1a,1
internet-delivered cognitive behavior therapy (icbt) for dysfunctional worry related to the covid-19 pandemic,1
intervention,1
intravenous access,1
interview by psychologists,1
intraosseous access,1
intranasal ivermectin spray,1
intranasal heparin sodium (porcine),1
intramuscular injection,1
intradermal injection of bcg vaccine,1
intracorporeal left hemicolectomy anastomosis,1
intestinal parasite,1
"intervention, tbn",1
intervention app,1
intervention training:,1
intervention program,1
intervention group_rehabilitation program,1
intervention group coronacope,1
intervention group,1
intervention for tecc model,1
intervention for covid-19 preventive protocols,1
in-person instruction,1
in vivo brain pet-tspo acquisitions,1
desidustat,1
hydroxychloroquine sulfate &azithromycin,1
hydroxychloroquine sulfate 600 mg twice a day,1
hydroxychloroquine sulfate 600 mg once a day,1
hydroxychloroquine sulfate 400 mg twice a day,1
hydroxychloroquine sulfate 200 milligram (mg) tab,1
hydroxychloroquine sulfate + azythromycin,1
hydroxychloroquine sulfate + azithromycin,1
hydroxychloroquine sulfate (hcq),1
hydroxychloroquine sar321068,1
hydroxychloroquine tablets,1
hydroxychloroquine pre-exposure prophylaxis,1
hydroxychloroquine plus standard preventive measures,1
hydroxychloroquine plus nitazoxanide,1
hydroxychloroquine placebo,1
hydroxychloroquine pill,1
hydroxychloroquine oral product,1
hydroxychloroquine only product in oral dose form,1
hydroxychloroquine sulfate tablets plus lopinavir/ ritonavir oral tablets,1
"hydroxychloroquine, azithromycin",1
hydroxychloroquine in combination of azithromycin,1
hyper immunoglobulins containing anti-corona vs2 immunoglobulin,1
hypertonic saturated saline mouth rinse active arm,1
hypertension,1
hyperpolarized xenon-129 mri of the lungs,1
hyperpolarized xe129,1
hyperpolarized 129xenon gas,1
hyperbaric oxygen treatment (hbot) i.e. inhalation of pressurized oxygen delivered by a hyperbaric chamber (drug/device),1
hyperbaric chamber,1
hyfe cough tracker,1
"hydroxychloroquine, clindamycin",1
hydroxycloroquine and azythromycine,1
hydroxychloroquine/chloroquine,1
hydroxychloroquine/azithromycine,1
"hydroxychloroquine, lopinavir/ritonavir or azithromycin and placebo (standard therapy)",1
"hydroxychloroquine, doxycycline",1
"hydroxychloroquine, clindamycin, primaquine - low dose.",1
"hydroxychloroquine, clindamycin, primaquine - high dose.",1
hydroxychloroquine in combination with camostat mesylate,1
hydroxychloroquine combined with azithromycin,1
hypothermia via cooling machine- arctic sun 5000,1
hospitalized patients for covid-19 infection,1
human ezrin peptide 1 (hep1),1
human cord tissue mesenchymal stromal cells,1
"human coach first, then virtual assistant",1
huaier granule,1
hscore,1
host immune factors,1
host genotype,1
hospitalized children with covid19,1
human milk donors,1
hospitalization for premature birth,1
hospitalization,1
"hospitalisation, necessity of icu, mortality rate, lung involvement",1
hospitalisation for sars-cov2 infection,1
hospital: usual care (uc),1
hospital: dd-ca,1
hospital treatment of covid disease,1
"human fecal microbiota, mbiotix hbi",1
human normal immunoglobulin (ivig),1
hydroxychloroquine as post exposure prophylaxis,1
hydroxychloroquine + azithromycin + / - tocilizumab,1
hydroxychloroquine and azithromycin treatment arm.,1
hydroxychloroquine and azithromycin treatment,1
"hydroxychloroquine , sofosbuvir, daclatasvir",1
hydroxychloroquine + sorbitol,1
hydroxychloroquine + placebo,1
hydroxychloroquine + metabolic cofactor supplementation,1
hydroxychloroquine + lopinavir/ritonavir,1
hydroxychloroquine (placebo),1
human umbilical cord derived cd362 enriched mscs,1
hydroxychloroquin with azithromycin,1
"hydrogen-oxygen generator with nebulizer, ams-h-03",1
hydrogen peroxide (b) mouth rinse with the solution provided,1
hydrogen oxygen generator with nebulizer,1
humoral and cellular immunity,1
humanistic care,1
human umbilical cord mesenchymal stem cells + best supportive care,1
hypothermia,1
"hypoxia : 14.3 and 12.7% fio2, hypercapnia 7% co2, inspiratory mechanical constraint",1
imunor,1
imatinib tablets,1
immune response study,1
"immune response monitoring , blood samples",1
immune response characterization,1
immune plasma,1
immediate vs. delayed provision of antibody test results,1
imm-101,1
imdevimab,1
imatinib mesylate intravenous solution,1
immunoformulation,1
imatinib mesylate,1
imatinib,1
"imaging, blood tests",1
imaging of the lungs,1
imaging by thoracic scanner,1
imaging,1
"ilr, pmk, icd",1
immunfluorescence,1
immunofree tablets and reginmune capsule,1
iloprost,1
"imp 5,000 plus soc",1
impulse™ una e-stethoscope,1
impliminting online distance learning,1
impact of respiratory isolation on quality of life,1
impact of event scale-revised,1
impact of covid-19 questionnaire,1
impact event score,1
imp rp2d plus soc,1
"imp 1,000 plus soc",1
immunogenicity after first and second dose,1
immunosuppressive agents,1
immunosuppressive,1
immunoseq,1
immunoglubulins,1
immunoglobulin of cured patients,1
immunoglobulin g detection,1
immunoglobulin,1
ilr implantation,1
ili and covid-19 detection,1
iamp test,1
icu cockpit software testing,1
idoine complex,1
identify sars-cov-2 infection by serology,1
identification of genetic variants,1
identification by pcr of the sars-cov-2 virus in samples taken from the fetus,1
id now™ covid-19 screening test,1
id now vs. accula,1
icu recovery + physical therapy,1
icosapent ethyl (ipe),1
ifn beta-1a,1
ice swimming,1
icatibant,1
"ic14, a monoclonal antibody against cd14",1
ic14,1
ibuprofen,1
ibudilast,1
"ib10 sphingotest® bio-adm® apparatus (sphingotec gmbh, hennigsdorf, germany)",1
ier-r (posttraumatic stress),1
igg,1
il-12 plasmid,1
iibr-100 high-dose (prime-boost),1
iiv4 for the 1st dose and ppv23 for the 2nd dose,1
iief-5 questionnaire,1
"iibr-100, low dose (prime)",1
iibr-100 top-dose (prime-boost),1
iibr-100 medium-dose (prime-boost),1
iibr-100 medium dose (prime),1
iibr-100 low-dose (prime-boost),1
iibr-100 high-dose (prime),1
igg antibodies immunoassay,1
igm and igg diagnostic kits to sars-cov-2,1
igm and igg antibodies assay,1
igiv,1
igg test,1
igg sars cov2,1
igg sars cov 2 antibodies,1
igg neutralising antibody titers to s1 and s2 proteins of sars-cov-2 virus,1
ivermectin (iver p®) arm will receive ivm 600 µg / kg once daily plus standard care. control arm will receive standard care.,1
ivermectin (ivm),1
ivermectin + doxycycline,1
machine learning/ai algorithm,1
mailer-based finger-prick,1
magnetic resonance spectroscopy (mrs).,1
magnetic resonance imaging,1
magec spine rod,1
maf capsules 148 mg,1
macrolide administered for up to 14 days,1
macrolide administered for 3-5 days,1
machine learning model,1
makair,1
machine learning classification of recurrence and non-recurrence,1
machine learning classification of parenchymal lung change cause,1
machine learning,1
machine based evaluation,1
m capsules 148 mg,1
lyt-100,1
lymphocyte monocyte ratio,1
maintenance or reduction of immunosuppression,1
male sexual health questionnaire (mshq),1
ly3127804,1
maraviroc+favipiravir+ct,1
mask without mask adhesive / arm 2,1
mask with mask adhesive/arm 1,1
mask,1
masitinib,1
"masimo, lidco",1
mas825,1
marker therapeutics d2000 cartridge (d2000) for use with the spectra optia® apheresis system (optia spd protocol),1
maraviroc experimental group,1
management of covid-19,1
maraviroc 300 mg,1
maraviroc + currently used therapy,1
maraviroc,1
manual acupuncture,1
manremyc,1
mannitol,1
management strategy of outpatient with mild to moderate sars-cov-2 pneumonia,1
ly3853113,1
lus twelve area,1
maslach burnout inventory (mbi),1
low-dose placebo (60-85 years) & three dose regimen,1
low-dose recombinant sars-cov-2 vaccine (cho cell),1
low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years) & two dose regimen,1
low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years) & three dose regimen,1
low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years) & two dose regimen,1
low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years) & three dose regimen,1
low-dose radiotherapy,1
low-dose placebo (60-85 years) & two dose regimen,1
low-dose placebo (18-59 years) & two dose regimen,1
low-intensity aerobic training,1
low-dose placebo (18-59 years) & three dose regimen,1
low-dose chest ct,1
low-concentration essential oil,1
low tailored message plus covid-19 vaccine message,1
low tailored message,1
low peep - fio2 low,1
low peep - fio2 high,1
low-field thoracic magnetic stimulation (lf-thms),1
low-intensity psychosocial interventions through telemental health,1
lus fourteen area,1
lung function test,1
lungfit™,1
lung ultrasound use in patients hospitalized with covid,1
lung ultrasonography,1
lung mechanics at different peep,1
lung low dose radiation,1
lung impedance technique,1
lung function tests,1
lung ct scan analysis in covid-19 patients,1
low-intensity remote patient monitoring (rpm-low),1
lung ct,1
lung biopsy,1
lucinactant,1
"ltx-109 gel, 3%",1
lsalt peptide,1
lower-dose prophylactic anticoagulation,1
low-molecular-weight heparin,1
masked saline placebo,1
maslach burnout inventory questionnair,1
ivermectin + doxycycline + placebo,1
mental health student,1
mesenchymal stem cells transplantation,1
mesenchymal stem cells derived from wharton jelly of umbilical cords,1
mesenchymal stem cell therapy,1
mesenchymal cells,1
merimepodib,1
"menthol 0.02%, methyl salicylate 0.05%, n- acetyl cysteine 1.2 gm%, and diclofenac sodium 1gm%",1
mental imagery,1
mental health questionnaire,1
mesenchymal stromal cells infusion,1
mencare+/bandebereho fathers'/couples' group education,1
menacwy vaccine,1
menacwy single dose + paracetamol,1
menacwy prime & saline placebo boost + paracetamol,1
menacwy boost,1
menacwy,1
membrane-based immunoassay kit,1
mesenchymal stromal cell-based therapy,1
mesenchymal stromal stem cells - ki-msc-pl-205,1
melatonin intravenous,1
methylene blue,1
"methylprednisolone, placebo",1
methylprednisolone therapy,1
methylprednisolone injection,1
methylprednisolone injectable product,1
methylprednisolone 80 mg/ml injectable suspension,1
methylene-blue photodisinfection,1
methylene blue 5 mg/ml,1
methotrexate-lde phase 2,1
mesencure,1
methotrexate-lde phase 1,1
metformin extended release oral tablet,1
metenkefalin + tridecactide,1
metaneb® system,1
messaging informed by construal level theory,1
messaging,1
message directing subjects to information on covid-19 vaccine safety and efficacy,1
melphalan,1
melatonin 2mg,1
massive parallel sequencing of host genome,1
measles-mumps-rubella vaccine,1
mechanical ventilation with the automated bvm compressor,1
mechanical ventilation,1
mechanical trombectomy,1
measurement of sublingual microcirculation,1
measurement of respiratory muscle force,1
measurement of oxygen saturation,1
measurement of circulating sflt1 concentration,1
"mcn (methylene blue, vitamin c, n-acetyl cysteine)",1
media intervention,1
mcgrath videolaryngoscope,1
mcc ims,1
maximal effort test,1
maternal stress,1
maternal sars-cov-2 infection,1
"maternal attachment, edinburgh depression scoring and postpartum anxiety scale scores",1
matched placebo hydroxychloroquine,1
mechanical ventilator settings and position,1
medical consultation,1
mejoracare,1
meditation app usage,1
mefloquine as a prophylaxis against sars-cov-2 infection in household contacts of covid 19 confirmed cases,1
mefloquine + azithromycin + / - tocilizumab,1
mefloquine,1
medium dose prednisolone,1
medium dosage inactivated sars-cov-2 vaccine on a 0- and 14-day schedule,1
medium chain triglyceride oil,1
meditation therapy,1
meditation and anxiety reduction training,1
medical follow-up,1
medication review,1
medical research council (mrc) dyspnea scale,1
medical record review - inpatient treatment,1
medical record review,1
medical ozone procedure,1
medical music,1
medical mask,1
low or upper respiratory tract sample,1
low molecular weight heparin as standard of care treatment,1
low intensity nudges,1
laboratory and instrumental examination,1
lactobacillus,1
labs,1
laboratory tests,1
laboratory test positive for sars-cov-2 virus,1
laboratory samples,1
laboratory blood tests,1
laboratory biomarkers,1
laboratory analyses,1
lactobaciltus rhamnosus gg placebo,1
lab workup (on admission and regularly during follow up).,1
l. reuteri dsm 17938 + vitamin d,1
kundalini yoga and anxiety reduction training,1
kukaa salama: mhealth intervention,1
koçak-19 inaktif adjuvanlı covid-19 vaccine 6 µg/0.5 ml vaccine,1
koçak-19 inaktif adjuvanlı covid-19 vaccine 4 µg/0.5 ml vaccine,1
knownow sars-cov-2 rapid antigen test,1
lactobaciltus rhamnosus gg,1
lactoferrin (apolactoferrin),1
kir phenotype evaluation,1
lateral position (left and right lateral decubitus),1
"lenalidomide as a 5 mg capsule po daily, days 1, 3, and 5.",1
learning running subcuticular sutures on the gamified educational network,1
leaf-4l6715,1
lb1148,1
lay telephone coaching,1
laughter theraphy,1
lau-7b,1
late-dexamethasone,1
"lactoferrin, green tea extract",1
late dexamethazone,1
laparoscopic or open appendicectomy,1
laparoscopic appendectomy,1
lanadelumab placebo,1
lamp,1
lambda 180 mcg s.c,1
lactose monohydrate,1
"knowledge, attitude, practice, awareness, preference",1
kinesiotherapy protocol,1
low flow ecmo driving by cvvh machine,1
"ivermectin 5 mg/ml oral solution, dexamethasone 4-mg injection, aspirin 250 mg tablets",1
ivermectin nasal,1
ivermectin injectable solution,1
ivermectin impregnated mask,1
ivermectin and doxycyline,1
ivermectin 6 mg oral tablet (2 tablets),1
ivermectin 6 mg oral tablet,1
"ivermectin 5 mg/ml oral solution, dexamethasone 4-mg injection, enoxaparin injection. inpatient treatment with mechanical ventilation in icu.",1
"ivermectin 5 mg/ml oral solution, aspirin 250 mg tablets",1
ivermectin oral tablets or sublingual waffles,1
ivermectin 3mg tab,1
ivermectin 3 mg,1
ivermectin 1.0mg/kg/day,1
ivermectin 0.6mg/kg/day,1
ivermectin 0.4mg/kg/day for 5 days,1
ivermectin / iota-carrageenan,1
ivermectin + placebo,1
ivermectin oral,1
ivermectin plus nitazoxanide,1
kevzara sc,1
kan jang capsules,1
ketotifen 1 mg,1
ketogenic diet with phytoextracts,1
ketamine,1
kelea excellerated water,1
kds-1000,1
kb109 + self supportive care,1
kaplan meier analysis,1
kamada anti-sars-cov-2,1
ivermectin powder,1
kaletra and beta interferon,1
js016 (anti-sars-cov-2 monoclonal antibody),1
jnj-78436735,1
"jinhua qinggan (jhqg) granules, traditional chinese medicine",1
janus kinase inhibitor (ruxolitinib),1
izephyr hood,1
ixekizumab,1
less-frequency hemodialysis,1
let it out (lio)-c,1
leukapheresis,1
lopinavir and ritonavir,1
lopinavir/ritonavir 200 mg-50 mg oral tablet,1
lopinavir/ritonavir + hydoxychloroquine,1
lopinavir/ ritonavir placebo,1
lopinavir/ ritonavir oral tablet,1
lopinavir/ ritonavir and remdesivir combination,1
lopinavir-ritonavir drug combination,1
lopinavir and ritonavir tablets,1
lopinavir 200mg/ritonavir 50mg tab,1
lopinavir/ritonavir 200 mg/50 mg film tablet,1
lopinavir 200 mg / ritonavir 50 mg [kaletra],1
"lopinavir / ritonavir, alpha-interferon nebulization,abidor hydrochloride",1
lopinavir / ritonavir tablets combined with xiyanping injection,1
lopinavir,1
longeveron mesenchymal stem cells (lmscs),1
longcovidkidsdk,1
longan nasal spray,1
lopinavir/ritonavir 200 mg/50 mg film coated tablet,1
lopinavir/ritonavir 400 mg/100 mg,1
leukotriene receptor antagonist,1
low dose (10 mg) control,1
"""calm"" is a mindfulness meditation mobile app",1
low dose radiation therapy (ld-rt),1
low dose radiation 35 cgy,1
low dose prednisolone,1
low dose of kbp-covid-19,1
low dose low molecular weight heparin or placebo,1
low dose interferon-beta 1a,1
low dosage inactivated sars-cov-2 vaccine on a 0- and 14-day schedule,1
lopinavir/ritonavir group,1
lovenox 40 mg in 0.4 ml prefilled syringe,1
lottery incentive,1
loss protection,1
losmapimod oral tablet,1
losartan 50 mg and spironolactone 25 mg pillules oral use,1
lopinavir/ritonavir treatment,1
lopinavir/ritonavir tablets or arbidol or chloroquine phosphate,1
lock-down and social distancing,1
local standard of care,1
lmwh,1
lidocaine,1
lifestyle (exercise),1
lifesignals biosensor 1ax*,1
lifelight® data collect oxygen saturation group,1
lifelight® data collect blood pressure group,1
life2000® ventilator,1
life questionnaires,1
lidocaine 2%,1
licorice extract,1
"liver, lung, heart and kidney biopsy",1
licensed seasonal influenza vaccine,1
licensed covid-19 vaccine,1
liberase enzyme (roche),1
lianhua qingwen,1
levilimab,1
levamisole pill + budesonide+formoterol inhaler,1
levamisole,1
lifestyle (meditation),1
lifestyle change promotion program,1
lifestyle program,1
lift,1
liver injury,1
"liver function tests ,serum ferritin and pcr for covid-19 .",1
liver function tests,1
liu-wei-di-huang formula,1
listerine zero mouthwash product,1
liquid alpha1-proteinase inhibitor (human),1
liposomal lactoferrin,1
linagliptin tablet,1
linagliptin 5 mg,1
linagliptin,1
limbix spark,1
lilly bamlanivimab + etesevimab,1
lilly bamlanivimab,1
ligilactobacillus salivarius mp101,1
lift mindfulness,1
hospital telemedicine management system,1
hospital standard of care for covid-19,1
hospital bedroom booking,1
enhanced response team,1
enoxaparin prophylactic dose,1
enoxaparin prefilled syringe [lovenox],1
enoxaparin higher dose,1
enoxaparin 40mg/0.4ml inj syringe 0.4ml,1
enoxaparin 1 mg/kg,1
eno breathe group,1
enisamium iodide,1
enhanced hygiene measures,1
enoxaparin/lovenox intermediate dose,1
enhanced follow through message,1
enduring happiness and continued self-enhancement (enhance) for covid-19,1
endothelial protocol,1
endothelial damage and angiogenic biomarkers,1
endoscopic procedure,1
endoscopic management according to standard of care,1
endoscopic intervention,1
enoxaparin sodium,1
enriched survey feedback,1
emtricitabine/tenofovir disoproxil fumarate 200 mg-245 mg oral tablet [truvada],1
ep,1
eproms assessment,1
epigenetic analyses,1
epidemiology of admissions,1
epidemiological and demographic characteristics,1
epic risk score display,1
epi-net intervention,1
epds (edinburgh postnatal depression scale),1
enzalutamide pill,1
ensifentrine dose 1,1
enzalutamide,1
environmental exposure and clinical features,1
entrée: interpersonal skills,1
entrée: cognitive skills,1
entrée: behavioral skills,1
ent exam,1
ensoetm device,1
encephalography measurement,1
emtricitabine/tenofovir disoproxil,1
eq001 placebo,1
electronic portable aromatic rehabilitation (epar) diffuser,1
elmo project at covid-19: proof of concept and usability,1
elispot: detection of the t cells specific to different sars-cov-2 proteins,1
elisa-test for igm and igg to sars-cov-2,1
elisa and rapid test to detect antibodies against covid-19,1
electronic survey questionnaire,1
electronic survey,1
electronic stethoscope,1
electrolytes,1
eltrombopag,1
electroencephalogram with ekg lead,1
"electrocardiography ,tomographic imaging",1
"electrocardiogram, transthoracic echocardiography and clinico-biological parameters in routine care",1
"electrocardiogram, telemetry, echocardiogram, laboratory values",1
electrocardiogram (ecg),1
electro impedance tomography,1
electrical stimulation - sham,1
elmo project at covid-19: study in humans,1
ema + automated text message intervention,1
emtricitabine/tenofovir alafenamide 200 mg-25 mg oral tablet,1
emotion regulation training via telehealth,1
emtricitabine/tenofovir,1
emricasan,1
emphasis of government involvement,1
emphasis of academic researchers involvement,1
emotional support plan,1
emotional freedom techniques (eft),1
emotional freedom technique,1
emergency ventilator splitter,1
ema alone,1
emergency surgical procedures,1
emergency surgery,1
emergency laparotomy,1
emergency general surgical admissions,1
emdr,1
embarrassment message,1
emapalumab,1
eq001,1
equine covid-19 antiserum,1
face mask,1
experimental: active care group,1
exposure to covid19,1
exposure to covid-19,1
exposure (not intervention) - sars-cov-2 infection,1
exposed to the novel coronavirus disease 2019,1
expiratory training device,1
experts consensus,1
experimental: questionnaire without precaution information,1
experimental drug,1
exposure to the dutch measures due to the covid-19 pandemic.,1
experimental,1
experiences in close relationship scale questionnaire (ecr-s),1
experience resolution methodology (erm),1
experience of pandemic,1
expanded hemodialysis for covid19 maintenance hemodialysis patients,1
exogenous surfactant,1
exo-cd24,1
"exposure to telemedicine, after the onset of the pandemic",1
"exposure to the fics annual meeting (june 9-11 2021, paris congress center)",1
exercise training group,1
extra-cvd virtual care,1
eye movement desensitisation and reprocessing recent traumatic event protocol,1
extravascular lung water index,1
extraoral vacuum aspirator (eva),1
extract psidii guava,1
extracorporeal membrane oxygenation,1
extracorporeal left hemicolectomy anastomosis,1
extracorporeal blood purification using the oxiris® (an69st) hemofilter,1
extra blood sample,1
exposure to the sars-cov-2,1
external evacuation device (eed),1
extended sampling and procedures,1
expression of receptors and activating proteases,1
exposure: positive covid-19 infection,1
exposure: negative covid-19 infection,1
exposure: covid-19 infection,1
exposure to the sars-cov-2 and its consequences,1
exg-5003,1
exercise test ecg,1
equipment with smartwatch throughout hospital stay on the general ward,1
esophageal catheter,1
estradiol patch,1
estradiol cypionate 5 mg/ml,1
estetrol monohydrate 15 mg,1
essential oils,1
essential oil blend,1
essential amino acids,1
essence oils,1
esoger,1
ethanol with asprin,1
escola l'horitzó,1
escola john talabot,1
escin,1
erucov-vac 6 µg/0.5 ml vaccine,1
erucov-vac 3 µg/0.5 ml vaccine,1
erucov-vac,1
eritoran,1
estrogen therapy,1
etoposide,1
exercise program,1
ex vivo expanded wharton's jelly mesenchymal stem cells,1
exercise physiology,1
exercise manual,1
exercise booklet,1
exebacase,1
exchange blood transfusion from normal donor,1
examine the impact of covid-19 during pregnancy,1
examinations for the research:,1
evaluation of the immunogenicity of the vaccine in haemodialysis patients,1
eucorvac-19,1
evaluation of the epidemiological characteristics of coronavirus infection (sars-cov-2),1
evaluation of skin microvascular flow and reactivity,1
"evaluation of clinical, instrumental and laboratory diagnostics tests",1
evaluation of changes in the diagnostic-therapeutic pathway for patients affected by pancreatic cancer,1
evaluation,1
evaluate hacor score effectivity in this patients,1
euroimmun assay,1
electrical stimulation,1
electrical impedance tomography (eit),1
electrical impedance tomography,1
digital oximeter monitoring,1
dipyridamole,1
diphenhydramine,1
dimethyl fumarate,1
digivis visual acuity app,1
digital storytelling intervention,1
digital social activity video intervention,1
digital problem solving tool,1
digital health online platform,1
dipyridamole er 200mg/ aspirin 25mg orally/enterally and standard of care,1
digital cardiac counseling,1
dig tilted,1
dig axial,1
diffusing capacity of carbon monoxide,1
difficulties lived by disabled children's parents in the period of covid-19 pandemic,1
differential leucocyte count (cldc) device and algorithm,1
differences in triage,1
dipyridamole 100 milligram(mg),1
direct antigen tests for covid-19,1
dietary supplement containing resistant starch,1
distribution of free face masks,1
dornase alfa inhalation solution,1
dornase alfa,1
doppler echo,1
doctorgram patient kit,1
doctor spot,1
doctella telehealth monitoring,1
dociparstat sodium,1
distilled water with the same colorant as the experimental product,1
direct laryngoscope,1
dissemination and implementation research,1
disease-modifying antirheumatic drugs (dmards),1
discussion board for social support+personalized feedback,1
discussion board for social support +basic feedback,1
discontinuation of arb/acei,1
discontinuation of acei/arb,1
direct laryngoscopy,1
dietary supplementation in patients with covid disease admitted to hospital,1
dietary supplement,1
electric pad for human external pain therapy,1
device: physiomer undiluted seawater nasal spray,1
dexmedetomidine injectable product,1
dexcom g6,1
dexamethasone oral,1
dexamethasone low dose,1
dexamethasone high dose,1
dexamethasone and hydroxychloroquine,1
dexamethasone 2 mg/ml,1
device used to record voice for screening,1
diabetes type 2,1
determination of sars-cov2 presence in cns,1
"determination of physical activity, quality of life, stress levels of isolated people at home with the danger of coronavirus.",1
determination of cyp2c19 genotype,1
determination of covid-19 vacciantion efficacy,1
detection of oral lesions,1
detection of anti-covid-19 antibody level,1
desmond,1
dfv890,1
diabetter together,1
dietary intervention,1
diagnostic tests for covid-19 infection,1
"dietary counselling on food groups according to iyc feeding practices, who",1
diet tracking and survey,1
diet and sun exposure,1
dianose,1
dialyzable leukocyte extract,1
dialysis,1
dialectical behavioral therapy (dbt) skills,1
diagnostic tests,1
"diagnosis of sars-cov2 by rt-pcr and : igg, ig m serologies in the amniotoc fluid, the blood cord and the placenta",1
diagnostic test:blood test,1
diagnostic test: serology test for covid-19,1
diagnostic test for sars-cov2 for patients and health staff,1
diagnostic test for detection of sars-cov-2,1
diagnostic test covid-19,1
diagnostic examination for venous thromboembolism,1
diagnostic,1
dose finding phase (mtd),1
double gloves,1
double-blind nt-i7,1
echo-doppler,1
edoxaban tablets,1
edinburgh postnatal depression scale (edps),1
edinburgh postnatal depression scale,1
economic freedom message,1
economic benefit message,1
ecmo implantation,1
echocardiogram 2d,1
ecg-holter,1
educational meetings and visual prompts,1
ecg from handheld device,1
ecco2r,1
eca-ace vaccination promotion intervention,1
eating habits,1
eat-26 questionnaire,1
easycov poc,1
earsats pulse oximeter probe,1
education sessions,1
educational program (cartoon),1
double-blind placebo,1
ehealth for covid-19 prevention and support,1
elective cancer surgery,1
elecsys semi-quantitative anti-sars-cov-2 antibody test,1
"elecsys anti-sars-cov-2 s (roche diagnostics gmbh, mannheim, germany), 2) access sars-cov-2 igg ii (beckman coulter, inc. usa)",1
ejaculated semen sample,1
eit-group,1
eicosapentaenoic acid gastro-resistant capsules,1
ei open ended pre-survey and semi structured interview,1
ehealth +counselling contacts,1
educational video,1
ehealth,1
eg-hpcp-03a placebo,1
eg-hpcp-03a,1
eeg based protocol for deep sedation,1
eeg,1
"educational, culturally appropriate covid-19 messages",1
educational vocal health modules,1
early rehabilitation,1
early occupational therapy,1
early definitive treatment,1
drug: isotretinoin plus tamoxifen,1
drugs and supportive care,1
drug: standard treatment standard treatment,1
drug: na-831 - 0.20 mg/kg,1
drug: na-831 - 0.10 mg/kg,1
drug: na-831,1
drug: isotretinoin(aerosolized 13 cis retinoic acid) plus aerosolized itraconazole,1
drug: isotretinoin(aerosolized 13 cis retinoic acid),1
drug: gs-5734 - 2.00 mg/kg,1
early access,1
drug: gs-5734 - 1.00 mg/kg,1
drug isotretinoin (13 cis retinoic acid ) capsules+standard treatment,1
drug covid19-0001-usr,1
dried blood spot and venous blood collection,1
draw blood,1
doxycycline hcl,1
doxycyclin,1
drugs: na-831 (0.10 mg/kg) plus gs-5734 (1.00 mg/kg),1
drugs: na-831 (0.20 mg/kg) plus gs-5734 (2.00 mg/kg),1
dräger antigen test sars-cov-2,1
ds-5670a,1
e-psychotherapy,1
e-ink screen,1
dysphagia handicap index (dhi),1
dysautonomia,1
dwj1248 with remdesivir,1
dvx201,1
duty frame,1
dutasteride 0.5 mg,1
during covid-19 pandemic,1
"duration of hospitalization, mortality rate",1
dur-928,1
duplex ultrasound and computed tomography angiography,1
duplex sonography,1
dupilumab,1
duact,1
f-652,1
face mask + soap,1
hospital anxiety depression scale,1
habit,1
hbcc project and soap,1
hb-admsc,1
handwashing stations at the public places and no soap,1
hads questionnaire,1
hads,1
had5-sfusion+ n-etsd (oral capsule),1
had5-s-fusion+n-etsd (suspension for injection),1
gx-i7 vehicle,1
hcq & az,1
gx-19,1
gustatory and olfactory function test,1
guilt message,1
guided online support program,1
guduchi ghanvati,1
gt0918 tablets or placebo,1
gse and xylitol,1
hcfwo,1
hcq & az vs hcq+sir,1
growth mindset ssi,1
healthcare providers' communication about the covid-19 vaccine,1
heat therapy,1
heart rate variability biofeedback,1
heart patch seeded with autologous cardiomyocytes and amnion epithelial stem cells,1
healthy minds program foundations training,1
healthy lifestyle advise,1
healthcare workers with the coronavac vaccine,1
healthcare worker focused outreach,1
health-related quality of life,1
hcq+azt,1
health warning leaflet,1
health questionnaire,1
health enhancement program,1
health care worker survey,1
hd-tdcs 4ma,1
hd-tdcs 2ma,1
hcq01,1
gs-441524,1
growth hormone,1
helmet cpap,1
glycomic analysis,1
graded exercise test,1
"gps reports of potential patient safety incidents, non-covid-19 related",1
gown personal protective equipment (ppe-g) suit,1
gossip intervention,1
go2 peep mouthpiece,1
gns561,1
gm-csf,1
glycaemic levels,1
grocery store gift cards,1
glutamine,1
glucose tablets,1
glucose control and sensor usage,1
gls-5310,1
gls-1200,1
gls-1027,1
global survey,1
gratitude,1
group 1,1
group1,1
group b (placebo),1
group hydroxychloroquine and apixaban,1
group hydroxychloroquine,1
group d:placebo oropharyngeal spray + placebo taken po,1
group c:active principle oropharyngeal spray + placebo taken po,1
group b: placebo oropharyngeal spray + active principle immunostimulant,1
group b control,1
group b (sample collection),1
group b (ag0302-covid19),1
group 1: rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed,1
group apixaban,1
group a: oropharygeal spray and immunostimulant,1
group a hcq,1
group a (sample collection),1
group a (placebo),1
group a (ag0302-covid19),1
group 2: control group with enoxaparin 40mg/d,1
helmet continuous positive airway pressure (cpap),1
helmet niv,1
face mask awareness,1
high-titer convalescent covid-19 plasma (ccp1),1
hlx70,1
hiv,1
hit-exercise,1
history of exposure to anti-cd20 treatment since 01/01/2010,1
hip arthropalsty,1
hiking challenge,1
high-titer covid-19 convalescent plasma (ht-ccp),1
high-titer anti-sars-cov-2 plasma,1
hmsc,1
high-titer anti-sars-cov-2 (covid 19) convalescent plasma,1
high-intensity remote patient monitoring (rpm-high),1
high-intensity aerobic training with high protein diet,1
high-flow nasal cannula treatment,1
high-dose recombinant sars-cov-2 vaccine (cho cell),1
high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years) & two dose regimen,1
high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years) & three dose regimen,1
hlx71,1
hmw-ha,1
high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years) & three dose regimen,1
home-based stretching and strengthening exercise,1
hospital anxiety depression measure,1
hospital anxiety and depression scale,1
hospital admission,1
"hormone levels (testosterone, fsh, lh, prolactin)",1
hope intervention,1
home-use test and follow-up questionnaire,1
home-cov rule implementation,1
home-based sars-cov-2 test kit,1
home care monitoring,1
home-based exercise training,1
home-based exercise,1
home spirometry,1
home sleep apnea testing or in-hospital polysomnography,1
home sample collection of concerning mole with physician supervision,1
home pulse oximetry monitoring,1
home exercise,1
high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years) & two dose regimen,1
high-dose placebo (60-85 years) & two dose regimen,1
helmet non-invasive ventilation,1
hepatitis a vaccine,1
high dosage inactivated sars-cov-2 vaccine on a 0- and 14-day schedule,1
hidroxicloroquina,1
hfno,1
hfb30132a,1
heterologous stimuli,1
hesperidin and diosmin mixture,1
hesperidin,1
heparin sc,1
high dose interferon-beta 1a,1
heparin infusion,1
heparin - therapeutic dosage,1
heparin - prophylactic dosage,1
hemopurifier,1
hemodynamics changes at different peep,1
hemodialysis by protein-leaking dialyzer for covid19 maintenance hemodialysis patients,1
hematology blood test,1
high dose corticosteroid,1
high dose of kbp-covid-19,1
high-dose placebo (60-85 years) & three dose regimen,1
high peep with end inspiratory pause,1
high-dose placebo (18-59 years) & two dose regimen,1
high-dose placebo (18-59 years) & three dose regimen,1
high-dose dexamethasone,1
high-concentration essential oil,1
high volume evacuation (hve),1
high touch multi-pronged behavioral intervention,1
high peep without end inspiratory pause,1
high intensity interval training group,1
high dose radiation 100 cgy,1
high intensity activities,1
high flow nasal therapy,1
high flow nasal oxygen (hfno) treatment,1
high flow nasal oxygen (hfno),1
high flow nasal cannula hfnc,1
high flow nasal cannula device,1
high flow nasal cannula,1
global longitudinal strain,1
glenzocimab,1
gimsilumab,1
fibromyalgia impact questionnaire,1
financial incentives,1
filtration test,1
filmarray pneumonia,1
filmarray pcr on respiratory samples,1
filling in an online survey,1
filiform needles,1
file inquiry,1
fibrin generation markers assays,1
fingertip tests for poc assays,1
fibreoptic endoscopic evaluation of swallowing (fees),1
fiberoptic bronchoscopy (fob),1
ffp3 respirator,1
"ffp2\n95 protective face mask (musk protective technology, gaziantep, turkey)",1
ffp2 respirator,1
ffp2,1
ffp,1
fingerstick,1
fingolimod 0.5 mg,1
fenofibrate/fenofibric acid,1
flucelvax,1
fnc dummy tablet+standard of care,1
fmd,1
fluzone high dose,1
fluvoxamine maleate 100 mg [luvox],1
fluvirin,1
fluoxetine tablets,1
fluorescein,1
flu shot,1
five-days oseltamivir,1
flow cytometry: detection of the sars-cov-2 specific t-helpers and cytotoxic t lymphocytes,1
flow cytometry,1
flow controlled ventilation (evone-ventilator),1
flavor test,1
fixed-duration hydrocortisone,1
fixed-duration higher dose hydrocortisone,1
fixed site standard of care testing,1
ferinject,1
feeling good digital app,1
giga-2050,1
faeces samples,1
fast dissolving film,1
farmalarm,1
famotidine 20 milligram tablet,1
famotidine 20 mg,1
familychildcare (provisional name of app),1
family risk messaging,1
family nurture intervention (fni),1
faecal sample collector,1
favicovir (standard treatment),1
facial mask,1
facial fractures reduction or osteosynthesis,1
facebook ads on the importance of staying safe during the thanksgiving / christmas holiday,1
face-to-face rehabilitation,1
face-to-face consultation,1
face-mask niv,1
face mask sampling,1
fatigue severity scale,1
favicovir 200 mg film tablet,1
feces samples (covi-biome ancillary study),1
favipiravir tablets,1
fecal and oral samples,1
fb2001 placebo,1
fb2001,1
favorable outcome,1
favira 200 mg film tablet,1
favir 200 mg ft,1
favipiravir tablets+chloroquine phosphatetablets tablets,1
favipiravir plus nitazoxanide,1
favipiravir (3200 mg + 1200 mg),1
favipiravir combined with tocilizumab,1
favipiravir and hydroxychloroquine,1
favipiravir + standard of care,1
favipiravir + currently used therapy,1
favipiravir (3600 mg + 1600 mg),1
favipiravir (3200 mg + 1200 mg) combined with hydroxychloroquine,1
favipiravir (3200 mg + 1200 mg) combined with azithromycin,1
fnc+standard of care,1
focus group discussions,1
focused/targeted message,1
gastroscopy in transnasal techique,1
gbp510 adjuvanted with alum (rbd 25μg/dose)- stage 2,1
gbp510 adjuvanted with alum (rbd 25μg/dose) - stage 1,1
gbp510 adjuvanted with alum (rbd 10μg/dose) - stage 2,1
gbp510 adjuvanted with alum (rbd 10μg/dose) - stage 1,1
gbp510 (rbd 25μg/dose)- stage 2,1
gbp510 (rbd 25μg/dose) - stage 1,1
gbp510 (rbd 10μg/dose) - stage 1,1
gastrointestinal endoscopy,1
gbp510 adjuvanted with as03 (rbd 10μg/dose) - stage 2,1
gastric cancer surgery,1
gas exchanges at different peep,1
gas exchange measurement,1
gargle/mouthwash,1
"garadacimab, factor xiia antagonist monoclonal antibody",1
ganovo+ritonavir+/-interferon nebulization,1
gamunex-c,1
gbp510 adjuvanted with as03 (rbd 10μg/dose) - stage 1,1
gbp510 adjuvanted with as03 (rbd 25μg/dose) - stage 1,1
folic acid,1
general public cohort,1
geneva emotional competence test (geco),1
genetic blood collection,1
genetic,1
generic best practices,1
generalized anxiety disorder-7 (gad-7),1
generalized anxiety disorder-7 (gad 7),1
general recommendation,1
general messages,1
gbp510 adjuvanted with as03 (rbd 25μg/dose)- stage 2,1
general lifestyle advice to breast cancer patients by phone,1
general health education,1
general communication message,1
gender concordant,1
geko t3,1
gc5131,1
gc4419,1
gammacore® sapphire (non-invasive vagus nerve stimulator),1
gammacore® (vagus nerve stimulation),1
gamification,1
food diary,1
frequency,1
freestyle libre 14 day cgm system,1
fp-025 300 mg,1
fp-025 100 mg,1
foy-305,1
fotv,1
fosmanogepix,1
fondaparinux,1
gam-covid-vac lyo,1
fondapariniux,1
follow-up visit,1
follow-up phone call,1
follow-up of patients with covid-19,1
follow-up based,1
follow-up at 14 days,1
follow up calls,1
fresh start,1
fsd201,1
fsfi survey,1
ft516,1
galidesivir,1
gad-7 general anxiety disorder scale,1
gad-7 (generalized anxiety disorder) scale (post containment),1
gad-7 (generalized anxiety disorder) scale (during containment),1
gad-7 (general anxiety disorder) scale,1
gad-7 (7-item generalized anxiety disorder),1
fx06,1
further processing of health data,1
furfat,1
fungal rhinosinusitis,1
functional mri,1
fultium® -d3 800,1
full vepmp intervention,1
full spectrum cbd oil,1
fulfilling questionaires,1
оxygen therapy,1
